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Abstract 
Improved Understanding of Apoptosis and Metabolism in 
Chinese Hamster Ovary Cell Culture 
by 
Ruiqiang 
Mammalian cell culture has gained importance in biotechnology for the 
development of therapeutic and diagnostic agents. Among them, Chinese hamster 
ovary (CHO) cells are regarded as the mammalian cell "workhorse". The use ofCHO 
cell line for the production of recombinant proteins used in human therapy has 
reached a level of industrial production. However, a major problem encountered in 
in vitro cultures is cell death via apoptosis. Since apoptosis leads to the loss of 
viability of mammalian cells in vitro, especially in serum-free media. This is 
important and necessary to prevent the activation of apoptosis cascade and increase 
their cell viability and enhance their cellular robustness. The overall goal of this 
study is to improve our understanding of the cellular and physiological 
determinants of apoptosis and its relationship with other cellular functions. 
Apoptosis is a result of a very complex network of signaling pathways 
triggered from both inside and outside of the cell and a highly regulated pathway by 
both pro-apoptotic and anti-apoptotic proteins that promote cell survival or cell 
death. Although many causes of apoptotic process in mammalian cell cultures had 
been researched in the past and have been discussed in recent years, a lot need to be 
explored. In order to bring novel strategies to understand apoptosis in mammalian 
cell cultures, our study was not only focused on the apoptotic pathway but also 
expand to metabolic network to set up a link between cell growth and apoptosis. In 
our project, we applied systems biology methods in a mammalian cell line (CHO TF 
70R), to understand the relationship between cellular metabolism and apoptosis in 
iii 
a typical serum free culture medium. After establishing the basic culture platform, 
the effects of culture conditions on initiating apoptosis will be evaluated. Healthy 
and apoptotic cell samples were identified and isolated using Fluorescence 
Activated Cell Sorting (FACS) and Magnetic Activated Cell Sorting (MACS), 
respectively. A comprehensive study of CHO cellular metabolism was made using a 
metabolic flux network to compare and analyze by metabolic flux analysis (MFA) to 
get more information on cell metabolism and apoptotic behavior. Furthermore, 2-
NBDG combined with Annexin V-PE was also successfully applied to estimate the 
glucose uptake rate in real early apoptotic cells. 
In summary, we used the integration of the data generated by MFA to 
understand apoptotic behavior and establish a correlation between cell regulation 
and apoptosis. It will help us to identify the changes during the onset of apoptosis 
process will be studied by using proteomics tools to analyze the protein up-
regulation or down-regulation in different cell status in the future. 
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Introduction 
Although mammalian cell lines are important hosts for the production of 
biopharmaceuticals, they have met some severe problems in bioreactors, especially 
cell death during culture processing is an inherent problem in current high density, 
serum free mammalian cell culture. Our work focuses on mammalian cell culture, 
specifically on addressing issues arising fromtheir culture in bioreactors. A mass of 
research has been conducted in this area. In this chapter, we briefly introduce the 
basic research motivation, project proposal goals and the outline of the thesis. 
1.1. Motivation 
Mammalian cells are widely used in the manufacturing of therapeutic 
proteins: human and veterinary vaccines, interferon, monoclonal antibodies and 
genetically engineered products[l] Mammalian cell cultures were developed just a 
century ago by embryologists Ross Harrison[2] , who published his findings on the 
growth of frog embryo nerve fibers in vitro. Since the first trial for human viral 
vaccines in the 1950s, mammalian cell culture has been accelerated to develop and 
become a mature technology with rapid expansion. Escherichia coli and mammalian 
1 
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cell lines are the workhorses of biopharmaceutical production. Although 
mammalian cell cultures are more technically complex, slow, and expensive 
compared to E. coli cultures, they satisfy the requirement of post translational 
modification of proteins for full bioactivity and native conformation. Thus, since the 
first human therapeutic protein, recombinant insulin, was licensed in 1982, more 
and more biopharmaceutical proteins produced form mammalian cell culture have 
been approved[3]. By 2003, 17 ofthe 32 therapeutic proteins approved are 
produced by mammalian cell lines. Recently, the number of approved 
biopharmaceutical by E. coli has decreased, which leads to the trend that the rate of 
biopharmaceutical approval has leveled off, while the approved proteins produced 
by mammalian cell increased, which bodes well for the future[4]. Figure.1 shows the 
increase in the amount ofbiopharmaceuticals approved from mammalian cell 
culture from 1986 to 2006. Starting in 2000, there has been a substantial increase in 
the manufacturing capacity to satisfy the demand[S]. 
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Figure 1 The demand for mammalian cell culture products[ 51 
CHO cell lines, which were first isolated by Puck et al. in University of 
Colorado Medical Center in 1957 [6], have been extensively used in the production 
of antibodies and recombinant glycoproteins such as Tissue Plasminogen 
Activator(tPA), Erythropioetin(EPO), factor III and Interferon- y (IFN- y )[7]. Since 
they can be adapted to suspension culture in serum free media, which satisfies the 
requirement of modern industry and of stringent safety, CH 0 cell lines have become 
the most important mammalian cell. Based on the data collected by /from several 
sources (http:/ /www.fda.gov, http:/ fwww.eudra.org/en_home.htm, 
http://www.phrma.org) [4], 24 biopharmaceuticals produced by CHO cells have 
approved in US or Europe since 1987, the time at which the first tPA produced in 
CHO cells was approved in US. 
However, a major problem faced by in vitro mammalian cell culture is cell 
death, which is caused by various factors. Apoptosis - programmed cell death - is a 
mode of cell death essential to the homeostasis of multi-cellular organisms and has 
been shown to occur in cultured mammalian cells. Apoptosis is frequently a barrier 
to maintaining viability and high cell densities. However, most mammalian cell 
death in culture has been attributed to apoptosis. Strategies to prevent apoptosis in 
mammalian cell culture can be broadly placed into two methods: manipulation of 
the culture environment or genetic manipulation Given that the onset of apoptosis is 
often triggered by conditions outside of the cells, one important strategy to inhibit 
cell death is to alter the physicochemical environment[8]. Nutrient feeding provides 
a potential solution for enhancements of culture longevity to inhibit apoptosis. On 
the other hand, from the point of view of preventing the apoptotic signaling cascade 
3 
from within the cell, chemical and genetic strategies are also used as effective 
methods. Chemical strategies targeting caspases, the downstream effectors of 
apoptosis, prevent these proteins from executing the cell death program and lead to 
sustained viability in mammalian cell bioreactors[9] Genetic strategies have also 
targeted caspases. The exogenous expression of gene effectively suppresses 
apoptotic signaling, limits cell death and maintains viability, such as Bcl-2 and Bcl-XL 
preventing the release of cytochrome c from the mitochondria [10]. In some sense, 
the most successful strategy will consider both metabolic engineering techniques 
and media formulations in combination with current bioreactor technology. 
The objective of this thesis is to develop methods for quantitative 
physiological studies for CHO cells in apoptotic process. In this regard, it is 
important to adopt and modify current methods and ideas in mammalian cell 
culture, and relevant biotechniques to achieve an improved understanding of 
apoptosis. 
1.2. Thesis Organization 
The thesis is organized into three major parts as follows: 
1. Quantitative characterization of defined apoptotic and healthy behaviors in a 
CHO cell. Cell heterogeneity almost undoubtedly exists within cell culture 
system. Quantitative characterization of apoptotic and healthy cells during cell 
culture was used to understand cultured mammalian cell behavior with respect to 
metabolic flux distribution, population survival heterogeneity and cell death. This 
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included using cell separation techniques such as FACS and fluorescence imaging 
technique to observe and detect apoptosis in CHO cell cultures. 
2. Experimental investigation and validation of healthy and apoptotic models in a 
"natural culture". This work is divided into two main parts: analysis of 
metabolites and metabolic flux analysis (MFA). The conventional experimental 
approaches entail the genetic and biochemical techniques to detect the activities 
of postulated metabolic events in apoptotic and healthy status to monitor the 
physiological states in combination with other parameters. The impact of specific 
metabolic pathways of key metabolites was evaluated via MFA to show the 
significant difference between healthy and apoptotic cells under a certain cultured 
condition. 
5 
Chapter 2 
Literature Review 
In this chapter, an overview of research system and tools is given. We briefly 
introduce mammalian cell culture and its metabolic behavior, apoptosis in vitro, cell 
separation technology, and metabolic flux analysis. 
2.1. Mammalian Cell Culture Technology 
Although prokaryotic cells are ideal host for expression of proteins because 
of their simplicity, ease of genetic manipulation and rapid growth, the synthesis of 
eukaryotic proteins presents a significant challenge due to their inability to carry 
out necessary post-translational modifications such as glycosylation and 
phosphorylation. In comparison to bacteria, mammalian cells are much more 
complex in structure and components and have more biological functionality[ll] . 
That is why they have long been used as the hosts for production of glycosylated 
therapeutic proteins that require precise post translational modification in order to 
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support their biological function. Then continuous cell lines, such as Chinese 
hamster ovary, CHO, baby hamster kidney, BHK, myeloma cells, NSO and SPZ/0, and 
human embryo kidney, HEK-293, were obtained and approved by regulatory 
agencies for industrial manufacture. Of these, CHO cells are a popular host for the 
production of recombinant proteins. CHO cell was first isolated in 1958 by Puck[6]. 
Since that time, cell cells have been widely used for producing recombinant proteins 
and many glycoprotein productions in CHO cells are approved. CHO cells provide an 
efficient host for the reliable synthesis and the expression of recombinant proteins 
including: tPA[12], EP0[13], Factor VIII[14], human growth hormone (hGH), 
humanized antibody (hAb), erythroid differentiation factor (EDF)[lS] 
Mammalian cell culture is a hybrid technology that combines many different 
disciplines such as biochemistry, cell biology, genetic engineering, protein chemistry 
and chemical engineering. It is a technology that has been applied to produce 
biopharmaceuticals. It has been developed during the last three decades and 
become an essential part of biotechnology. Medicines from mammalian cell culture 
focus on the use of cell culture to produce human and veterinary vaccines, 
interferon, monoclonal antibodies and genetically engineered products. Most of 
these cell lines can be cultured in suspension culture as opposed to an anchorage-
dependent mode, make large scale cultivation achievable in sparged, stirred tank 
bioreactors. 
A typical upstream cell culture process development can be described as 
following. First, a number of high-producing cell clones are obtained by state-of-the-
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art transfection, amplification, and selection methods. Then cell culture medium is 
customized to support the growth of various cell clones. The medium normally 
contains more than 60 synthetic ingredients with well-defined concentrations, 
including carbon sources, amino acids, salts, vitamins, lipids, growth factors, and 
buffers. Because of the disadvantages of batch variation and vulnerability to 
contamination, serum and other animal components are required to be eliminated 
from medium formulation. Finally, bioreactor operation parameters are optimized 
in order to achieve consistent product quality and high protein expression level. 
Small scale bioreactors are used to determine acceptable range of pH, DO, 
temperature, and inoculation density. Then the cell culture process is scaled-up to 
production levels of 20,000 L, or greater. Overall, the improvement of host cell line 
engineering, media optimization, and bioreactor operation in last two decades 
resulted in a dramatic increase of product titer to the range of grams per liter. 
2.2. Metabolism of Mammalian Cell Lines 
Mammalian cell lines are used to produce therapeutic proteins, so the 
characterization and understanding of their basic metabolism are needed to 
improve cell lines' performance in culture systems. Metabolic profile is the 
simultaneous assessment among major metabolic pathways of macromolecule 
synthesis and energy production under growth phases and physiological conditions. 
Metabolic pathways of central importance include glycolysis, tricarboxylic acid 
(TCA) cycle, pentose phosphate pathway (PPP), oxidative phosphorylation, 
8 
glutaminolysis, the metabolism of other amino acids and biosynthetic pathways.[7] 
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Figure 2 shows the outline of important pathways for mammalian cell 
metabolism. The central metabolic pathways are of key importance from the 
perspective of metabolic engineering because they are including common pathways 
from which fluxes are distributed to different branches. In these pathways, carbon 
sources are catabolized to produce energy, reducing equivalents and the precursors 
for biosynthesis. Since central metabolic pathways are very import points of 
intervention, in this study the focus is on these parts. In contrast to bacterial and 
plant cells, mammalian cell lines cultured in vitro exhibit a highly deregulated 
metabolism in central metabolic pathways, which is characterized by a very high 
and inefficient consumption of the main energy sources, leading to the accumulation 
of lactate and ammonium ions in the culture media. From the analysis of glucose 
and glutamine utilization, products rates and glycolytic flux and measurement of the 
maximal activities of some key enzymes of glycolysis, glutaminolysis and TCA cycle, 
most of glucose, about 70% to 99.8% [16], was found to be oxidized to pyruvate and 
finally to lactate. This causes acidification of cell medium. And it is show a very low 
flux of glucose via TCA cycle and no or very low activities of the key enzymes 
connecting glycolysis with the TCA cycle [1, 17]. However, in general, an active TCA 
cycle is prerequisite for efficient growth. Thus, to satisfy the energy requirements, 
mammalian cells consume more glutamine, which will lead to the generation of 
more ammonia. So in this case, glutamine or glutamate is also the main energy 
source in mammalian cells. Thus glutamine or glutamate oxidation drives carbon 
entering TCA cycle through glutaminolysis. 
10 
2.2.1. Energy source metabolism 
Glucose and glutamine are the main compounds. The significant point is the 
metabolism of glucose and glutamine generate more lactate and ammonium. Figure 
2 shows metabolic energy network of glucose and glutamine degradation, which 
include glycolysis, TCA cycle and glutaminolysis. Arrows with dashed line indicate 
that the respective metabolic pathway does not exist or its activity is very low in 
cultured mammalian cells. 
2.2.1.1. Glucose Metabolism 
The first step in metabolism of a substrate is its transport across the cell 
membrane. The cytoplasmatic membrane is impermeable to polar molecules such as 
glucose, and the uptake of glucose through membrane is the work of the transport 
proteins located in the plasmatic membrane. Most researches were focused on 
glucose transport. Several kinds of factors control this system. A family of related 
proteins is responsible for this transport activity in mammalian cells such as GLUT 1 
and GLUT 4 glucose transporters[18]. In addition to the facilitated diffusion by 
GLUT series, glucose transfer can also happen through sodium symport process 
[19]. After the substrate is transported into the cell, it is fed to the bioreaction 
network. 
Once entering the cytosol, glucose will be converted by two main pathways: 
glycolysis and PPP. Once glucose is phosphorylated by hexokinase, glucose 6-
phosphate (G6P) is formed. There are two enzymes determining the pathways of 
11 
G6P, G6P isomerase and G6P dehydrogenase. G6P isomerase channels G6P to 
glycolysis and G6P dehydrogenase to PPP. In glycolysis, G6P is converted to 
pyruvate, generating a lot of intermediates for biosynthesis, two A TP and two 
NADH. However, glycolysis is deregulated in cultured mammalian cells, which is 
highly linked to the generation of large amount of lactate that we have mentioned 
ahead, that indicates that a low percentage of pyruvate is incorporated into the TCA 
cycle. This is because of the lack of these specific enzyme activities, such as pyruvate 
dehydrogenase complex (PDHC), phosphoenolpyruvate carboxykinase (PEPCK) or 
pyruvate carboxylase (PC), directly causing this imbalance rate between glycolysis 
and TCA cycle. Other biosynthesis precursors provided by glycolysis pathways are: 
fructose 6-phosphate (F6P) for the synthesis of amino sugars; dihydroxyacetone 
phosphate (DHAP) for lipid synthesis; and glycerate 3-phosphate, precursor for 
synthesis of serine and glycine[7]. 
As discussed previously, low level glucose is transferred into TCA cycle. 
However, TCA cycle is still a major pathway in the central metabolism, which 
provides metabolic energy and biosynthesis precursors. The TCA cycle is directly 
relevant to metabolic energy generation in the form of ATP based on the respiratory 
system. It is also very important to balance the rate of glycolysis and glutaminolysis 
[7]. The pyruvate node is the juncture between glycolysis and TCA cycle. Pyruvate is 
first transported into the mitochondria and further dissimilated into Acetyl 
coenzyme A (AcCoA). In mammalian cells, some enzymes lacking activities are just 
in this node, which directly causes an imbalance between glycolysis and TCA cycle 
and leads to ample lactate. Paredes et al analyzed the flux from pyruvate to AcCoA 
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through PDHC in a hybridoma cell line, the values was less than 1% [20-21] AcCoA 
enters the cycle reacting with oxaloacetate to form citrate. Citrate then undergoes a 
series of reaction to generate COz, NADPH and a-ketoglutarate in this cycle. 
However, at this point, a flux of citrate leaves the TCA cycle and is exported to 
cytosol for lipid formation[?]. Thus, both the low incorporation of AcCoA into TCA 
cycle and the outflow of citrate towards lipid reduce the flux in the TCA cycle. So in 
order fulfill the energy generation, glutamine becomes the replenisher at the point 
of a-ketoglutarate. Mancuso A et al found that the flux from citrate to a-
ketoglutarate was only about 10% of the flux through citrate synthase in hybridoma 
cells[22]. Because of the high uptake of glutamine and the anaplerotic reaction of a-
ketoglutarate, the flux from succinate to malate is higher than the flux from 
oxaloacetate to citrate. Thus extra malate leaves TCA cycle and further is converted 
to pyruvate via malate shunt[7]. 
2.2.1.2. Glutamine/glutamate metabolism 
Glutamine/glutamate is the second major component and the source of most 
of the ammonium generated. In addition to the important role as an energy source 
via TCA replenishment as mentioned previously, glutamine is also a nitrogen source 
for first use in synthesis ofprydine, purine, amino sugars, NAD and asparagines, and 
also second necessary for the synthesis of praline and ornithine[?]. 
Glutamine or glutamate transport is through principal amino acid transport 
systems, just as many other amino acids' movements to cell membrane. Na+ 
dependent and Na+ independent appear to mediate amino acid uptake[23]. In Na+ 
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dependent system, glutamine or glutamate is cotransported with Na+ against their 
concentration gradient by Na+ jK+-ATPase[7]. In Na+ independent system, it 
facilitates the selective movement of amino acids across the membrane by 
catalyzing exchange rather than net uptake[23]. In addition to the transport from 
media to cytosol, transport mechanism around the mitochondria is very important, 
since most of the glutamine metabolism inside of the mitochondria. An important 
enzyme, phosphate activated glutaminase (PAG) is located either in the 
mitochondrial membrane or matrix. It can cause the deamination of glutamine to 
form glutamate, which can be transported into the mitochondria by glutamate-
aspartate exchanger or the proton symport system[7]. 
Once glutamate is transported, its fate is determined by glutamate 
dehydrogenase (GDH) or transaminases. GDH deaminates glutamate to a-
ketoglutarate and channels it towards TCA cycle. Transaminases, such as alaT A and 
aspT A channel glutamate towards transamination (TA) reactions. The role of 
glutamine metabolism in the generation of oxaloacetate has been highlighted 
previously, since the anaplerotic reaction of TCA cycle. In this cycle, it can be 
completely oxidized to C02, for energetic yield (up to 27 ATP per glutamine)[?]. In 
T A pathway, glutamate reacts with oxaloacetate to form aspartate or with pyruvate 
to form alanine, while glutamate itself is also converted into a-ketoglutarate. 
Aspartate and alanine can be further converted into purine, pyrimidine and 
asparagine. So the released ammonium from glutamate to a-ketoglutarate is 
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transferred. Thus the TA pathways balance ammonium overflow due to the rapid 
glutamine consumption in mammalian cell culture. 
2.2.1.3. The metabolism of other amino acids 
Unlike prokaryotic cells, cultured mammalian cells cannot synthesize the 
branched chains or ring systems in amino acids. Thus, these kinds of amino acids 
are essential, which includes arginine, histidine, isoleucine, leucine, lysine, 
methionine, phenylalanine, threonine, tryptophan and valine. However, in cultured 
mammalian cells, alanine, asparagine, aspartate, cysteine, glutamate, glutamine, 
glycine, proline, serine, and tyrosine can be synthesized. Among these nonessential 
amino acids, glutamine or glutamate is required in high quantities duo to the role of 
energy source in mammalian cells. Alanine is the greatest amino acid product of 
glutamine metabolism and about 40% of the glutamine can be converted to alanine 
as end product[?). Asparagine is produced by the amidation of aspartate which 
comes from T A reaction between glutamate and oxaloacetate. Proline is formed 
directly form glutamate accumulation. The amounts of these amino acids are 
changed due to the cell physiological states. However, the amounts of some amino 
acids such as threonine, arginine, phenylalanine, serine histidine, methionine and 
glycine keep constant or are consumed in very fair amounts. All of these amino acids 
can be connected by TCA cycle (figure 3). So, the amounts of these amino acids must 
be appropriately balanced. Amino acids must be supplied form the media to ensure 
the metabolic functions of mammalian cells and supply the required amounts in a 
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balanced state. The absence of any of these amino acids would trigger the onset of 
cell death.[?, 11, 17] 
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Figure 3 Interaction of the metabolism of the amino acids in central 
metabolism. 
2.2.1.4. Effect of lactate and ammonium in Mammalian cell Metabolism 
Lactate and ammonium are main end products of mammalian cell 
metabolism. As mentioned previously, the accumulation of lactate and ammonium 
derive from the high glucose and glutamine consumption. Both of them have 
inhibitory effect on cell growth. However, generally, the direct inhibition of 
ammonium is much more serious than that of lactate. 
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Lactate generation by mammalian cells has been mentioned in glucose 
metabolism. The large amounts oflactate have great effect on mammalian cell 
growth (Table 1). If a critical concentration is exceeded, lactate can become 
inhibitory to cell growth. Generally, lactate concentration below 20 mmolfL has not 
any negative effective effects[11]. 
Table 1 Effects of lactate concentrations on cell growth at constant pH 
Lactate Growth Productivity Reference 
concentration(mmol/L) 
<20 No effect No effect Wagner[24], 
Miler[25] 
20-40 No effect Inhibition Glacken[26] 
40-60 Slight inhibition Inhibition Glacken[26] 
>60 Inhibition Inhibition Glacken[26] 
Ammonium can inhibit growth and productivity. Ammonium ions compete 
with potassium ions for inward transport via potassium transport proteins such as 
the Na+jK+-ATPase[7]. McQueen[27] eta/ assumed an effect of ammonium by a 
reduction of the intercellular pH value. Some key enzyme such as PFK can be 
inactivated by the increase of the ammonium concentration. Moreover, cells can be 
adapted to ammonium concentrations up to 5 mmolfL (Table 2). In some report, 
cell were tolerant up to maximum values of around 30mmolfL[28] 
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Table 2 Effect of ammonium on cell growth and productivity 
Ammonium Growth Productivity Reference 
concentration(mmol/L) 
<2 No effect No effect Glacken[26] 
2-5 Inhibition No effect Glacken[26] 
McQueen[27] 
>5 Inhibition Inhibition Glacken[26] 
It should be considered that although most attention has been given to the 
potential toxic effect of lactate and ammonium, there is experimental evidence that 
other substances may also cause negative effects on cellular behavior[29] 
2.3. Apoptosis in Mammalian Cell Culture 
In mammalian cell culture, cell death is an ineluctable phenomenon that is 
different from bacteria. No matter what kind of culture, in vivo or in vitro, cell death 
is part of the normal development and it is the result of many response patterns. For 
every cell, there is a time to live and a time to die. Cell death can occur by either of 
two distinct mechanisms, necrosis or apoptosis. Though it is now extensive thought 
that the failure of cell death, especially apoptosis (also known as programmed cell 
death) may be very important in the development of cancer, viral infection and 
autoimmune disorders[30]. Recent research findings show that it is also an 
important mechanism in mammalian cell lines in vitro [7, 31-33] Apoptosis is the 
regulated form of cell death, which is a complex process defined by a set of 
characteristic morphological and biochemical features. Although apoptosis, 
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involving many different pathways and signals, is a very complex process in 
eukaryotic cells and not fully understood at present, To date, approximately 14 
mammalian caspases have been identified and can be roughly divided into three 
functional groups: apoptosis initiator (including caspase-2, -9, -8, -10), apoptosis 
effector (including caspase-3, -6, -7), and cytokine maturation (including caspase-1, 
-4, -5,-11,-12,-13, -14)[31, 34-35].Two main pathways predominate the whole 
program[36-37].1n mammalian cells, the apoptotic response is mediated through 
either the intrinsic or the extrinsic pathway [38]. The extrinsic pathway is induced 
by the ligation of plasma membrane death receptors and the intrinsic pathway is 
caused by a change in the mitochondria due to a perturbation of intracellular 
homeostasis. Both pathways finally converge on the proteolytic activation of 
downstream effector caspases[39]. 
Kraemer eta! divided apoptosis into three stages[40]: 
1) Signaling phase: cell receives an internal or external signal to activate 
signal transduction pathways. 
2) Effector phase: in this phase, various pathways influence the cell to 
further commit to apoptosis. The relative levels of both pro-apoptotic 
and anti-apoptotic proteins are critically involved in this phase. 
3) Degradation phase: essential proteins will degrade in this phase. And 
most of the morphological features of apoptosis are found to occur. 
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2.3.1. Apoptotic pathways 
As mentioned previously, there are two characterized apoptotic pathways, 
intrinsic and extrinsic pathways (figure 4)[41]. Both pathways lead to activation of 
caspase-3 and give rise to apoptosis. 
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Figure 4 an overview of the intrinsic and extrinsic pathways(42] 
The intrinsic pathway is triggered by death stimuli which are generated 
inside of the cell, such as oncogene activation, DNA damage and ER stress[43]. The 
intrinsic pathway is mediated by mitochondria and regulated by Bc/-2 family that 
can either promote survival or apoptosis, playing a pivotal role in this process[31, 
43]. In the intrinsic mitochondria-mediated pathway, apoptosis is initiated by the 
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release of cytochrome c into the cytosol. In the presence of an apoptotic stress as 
serum deprivation, heat shock and chemical toxins, cytochrome c will be released 
from the mitochondria. Bcl-2 family modulates cytochrome c release. The 
cytochrome c, released from the mitochondrial intermembrane space to cytoplasm, 
works together with the other two cytosolic protein factors, apoptotic protease 
activating factor-1 (Apaf-1) and procaspase-9, to promote the assembly of a caspase-
activating complex termed the apoptosome, which in return induces activation of 
caspase-9 and thereby initiates the apoptotic caspase cascade [44-45]. 
The extrinsic pathway is triggered on the cell surface via binding 
extracellular death ligand like FasL, tumor necrosis factor a (TNFo:) and apo3-
ligand, to the death receptors, such as Fas and death receptor(DR) 3, 4, 5, or 6[45-
46]on the surface of the cell receive death signals and the result is that procaspase-8 
is auto catalytically cleaved into its active form, which results in apoptosis 
execution[43, 46]. Generally, death receptors has an extracellular region containing 
cysteine-rich domains[47] for ligand binding, and an intracellular region with a 
death domain (DD) motif, which can trigger homotypic protein-protein interactions. 
Adapter molecules like FADD or TRADD themselves possess their own DDs by 
which they are recruited to the DDs of the activated death receptor. These 
homotypic interactions lead to form death-inducing signaling complex (DISC), which 
can trigger procaspase-8 cleavage. Then the active caspase-8 triggers the release of 
mitochondrial proteins that results in apoptosis [47]. At the point of active caspase-
8, the extrinsic apoptosis pathway forks here. Type I is a direct pathway that 
downstream effecter caspases such as caspases-3, -6 and -7 are activated by active 
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caspase-8. In type II, there are lower levels of active caspase-8[48]. Thus, the signal 
needs to be amplified via mitochondria-dependent apoptotic pathways. This type is 
the link between extrinsic and intrinsic pathways by the Bcl-2 family member Bid. 
Bid is cleaved by active caspase-8 to form truncated Bid (tBID), which induces the 
release of cytochrome c. Type II induced apoptosis is block by Bcl-2 over-
expression, while type I is not[ 4 7]. 
2.3.2. Apoptosis vs. Necrosis 
Cell death is reported to occur by two different and alternative modes: 
apoptosis, an active, programmed cell death of autonomous cellular dismantling and 
necrosis a passive, unordered and accidental cell dying resulting from 
environmental perturbations with uncontrolled release of inflammatory cellular 
contents. There are many observable morphological and biochemical differences 
between apoptosis and necrosis [49-52]. 
Apoptosis includes cellular shrinking, chromatin condensation and 
margination at the nuclear periphery with the eventual formation of membrane-
bound apoptotic bodies that contain organelles, cytosol and nuclear fragments and 
are phagocytosed without triggering inflammatory processes. The necrotic cell 
swells, becomes leaky and finally is disrupted and releases its contents into the 
surrounding tissue resulting in inflammation. Figure 5 is the sketch of the processes 
of two kinds of cell death[53]. 
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Figure 5 the process of Apoptosis and necrosis. Apoptosis includes cellular 
shrinking, chromatin condensation and margination at the nuclear periphery 
with the eventual formation of membrane-bound apoptotic bodies that 
contain organelles, cytosol and nuclear fragments and are phagocytosed 
without triggering inflammatory processes. The necrotic cell swells, becomes 
leaky and finally is disrupted and releases its contents into the surrounding 
tissue resulting in inflammation. Modified from [32]. 
Morphological, biochemical, and physiological differences are listed in Table 
3[50, 53]. 
Table 3 Differential features and significance of apoptosis and necrosis 
Apoptosis Necrosis 
Morphological features 
Membrane blebbing, but membrane 
integrity maintained 
Aggregation of chromatin at the nuclear 
Membrane integrity lost 
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membrane 
Begins with shrinking of cytoplasm and 
condensation of nucleus 
Ends with fragmentation of cell into 
smaller bodies 
Apoptotic bodies form 
Begins with swelling of cytoplasm and 
mitochondria 
Ends with total cell lysis 
No vesicle formation, complete lysis 
Biochemical features 
Tightly regulated process 
DNA cleavage 
Energy dependent 
Loss of regulation of ion homeostasis 
No DNA cleavage 
Energy independent 
Physiological significance 
Affects individual cells 
Induced by physiological stimuli 
No inflammatory response 
Affects groups of contiguous cells 
Evoked by non-physiological 
disturbances 
Significant inflammatory response 
2.3.3. Apoptosis in Mammalian Cell 
Though apoptosis is widely developed in cancer and AIDS[47], a bundle of 
evidence shows it is also an important mechanism during the in vitro mammalian 
culture[54], especially in serum free suspension culture, which makes the cell more 
susceptible to death[16, 54]. Evidenced by condensed chromatin and the 
appearance of a characteristic DNA ladder, 60-90% of total cells die via 
apoptosis[17, 55], and the exact ratio depends on the type of mammalian cell line, 
mode of culture and cultivations conditions. Healthy and apoptotic CHO cells in 
bioreactor are distinguished by acridine orange and ethidium bromide staining 
(Figure 6). Although apoptotic bodies can be phagocytosed in vivo, in vitro they 
might break apart or accumulate during the cell culture process. Mammalian cells 
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are prone to apoptosis when cultured in large scale for production of 
biopharmaceuticals. And this will reduce production duration and results in high 
cost of production. Apoptosis is triggered by various factors, and delicately 
regulated by a set of genes [16, 31]. 
To understand apoptosis in mammalian cell culture, it is necessary to 
consider the insults that may initiate apoptosis. In spite of best efforts to maintain 
an optimal environment, cells are constantly changing conditions. Non-optimal 
conditions can produce cell death. It also has been shown that the accumulation of 
toxic byproducts, ammonia and lactate, can cause apoptosis[25, 56]. In high-density 
cell cultures, apoptosis is often induced by the depletion of glucose and glutamine. 
Wong et al [38] found some up-regulation of apoptosis genes such as FasL, Rip1, 
Bak, Caspase-8, and -9 occurred at the stationary phase in CH 0 batch culture, which 
coincided with the depletion of glucose and glutamine. 
Blebbing 
C roman 
conden~tion-
Apoptotic CHO cell 
Figure 6 Healthy and apoptotic CHO cells stained with acridine orange and 
ethidium bromide[16] 
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The generation of reactive oxygen species (ROS) during culture, either as a 
result of oxygen sparging or cellular metabolism, may trigger apoptosis. Atsumi et 
al[57] found that the potent phophatidylserine (PS) externalization and loss of the 
potential of mitochondria appeared to be mediated by ROS generation, which 
showed the relationship between early apoptosis and the induction ofROS 
generation. Stephanopoulous et al [58] found that free fatty acid-induced ROS 
generation and apoptosis are accompanied by the decoupling of glycolysis and TCA 
cycle leading to abnormal cytosolic redox states. Thus, antioxidants such as N-
acetylcysteine have been used in mammalian cell culture to prevent apoptosis[59]. 
Recent evidence has shown NAD(P) is essential to mediate cell signaling 
processes[60] in addition to its role in basic metabolism. The depletion of the 
cytosolic NAD+ pool makes the cells unable to utilize glucose, which leads to 
apoptosis. Ying et al[61] analyzed the functions of cytosolic NAD+ in supporting the 
flux of glucose and reducing equivalents to the mitochondria and suggested that a 
sequence of events in which NAD+ depletion plays an essential role of linking 
metabolic impairment and apoptosis. 
Mitochondria play a complex role in the control of apoptosis and they 
participate directly in the apoptotic pathway as the site of action of Bcl-2 and 
caspase activity and interaction[43, 47, 61]. Intracellular signals that induce 
mitochondrial membrane permeability transition leads to release of cytochrome c. 
On the other hand, mitochondrial ATP generation seems to be required for 
apoptosis to proceed [ 43, 4 7]. Mitochondria are not only the key regulatory centers 
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for the genesis of apoptosis, but are also the metabolic centers that provide energy. 
It is believed that mitochondrial dysfunction, and consequently alterations in energy 
metabolism, is an important event during apoptosis. 
Generally, numerous insults present in the bioreactor environment that may 
promote cell death via apoptosis. Changes in the intracellular environment resulting 
from metabolic stress also have a significant impact on induction of apoptosis. 
Identification of the metabolic changes and the apoptotic pathways should lead to 
an enhanced ability to understand apoptosis during mammalian cell culture. 
2.3.4. Methods for apoptosis inhibition 
Because the induction of apoptosis can lead to the loss of viability in 
bioreactors, it is of considerable value to be able to prevent or inhibit apoptosis in 
mammalian cell culture in order to extend the time span of high cell viability. 
Several methods have been developed and evaluated to limit the activation of 
apoptosis. Normally, there are two kinds of strategies that have been applied to 
inhibit or slow the onset of apoptosis in bioreactors: the alteration of the external 
environment via media supplementation and genetic manipulations. 
2.3.4.1. Media supplementation 
Because the external environment often triggers the onset of apoptosis in 
vitro, altering the conditions of media can be an effective approach to enhance cell 
robustness. 
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The most common strategy is the utilization of a fed batch mode of 
cultivation, which we have mentioned above. Fed batch not only control the 
concentration of nutrient, but also regulate some critical parameters such as 
dissolved oxygen and pH and reduce toxic byproduct as well as lactate and ammonia 
concentration. In high-density cell cultures, apoptosis is often induced by the 
depletion of glucose and glutamine. Wong et al [38] found some up-regulation of 
apoptosis genes such as FasL, Ripl, Bak, Caspase-8, and -9 occurred at the 
stationary phase in CHO batch culture, which coincided with the depletion of 
glucose and glutamine. Thus, appropriate feeding strategies can delay onset of 
apoptosis in culture. In some sense, fed batch is a simple and good strategy to delay 
apoptosis. However, since apoptosis is induced by conditions other than depletion 
of nutrients, cell death in fed batch is not due to nutrient limitation and will also 
appear in the end of culture. 
Although serum is known to contain unidentified anti-apoptotic chemicals 
that can provide protection of cell viability during all stages in culture[62], cell 
growth in serum free medium is often a requirement for current industrial 
condition. Therefore, some supplements have been considered as independent anti-
apoptotic factors. Zanghi et al [63] found that suramin, which is drug used for 
treatment of human sleeping sickness and onchocerciasis caused by trypanosomes, 
protects CHO cells in serum free culture from apoptosis during exponential growth 
phase but does not work in death phase as an active site-directed, reversible and 
tight-binding inhibitor of protein tyrosine phosphatases[64]. Similarly, other 
specific inhibitors are available to suppress apoptosis such as transferring or insulin 
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growth factor, which can replace insulin as a mitogen and inhibit apoptosis[16]. 
Silkworm hemolymph may decrease cell detachment from an adhering surface and 
then inhibits apoptosis in mammalian cell culture[65]. Heat shock proteins of the 
hsp70[66] family protects cell against various cytotoxic agents and apoptotic stimuli 
(Table 4). However, not all of them are appropriate to large-scale culture because of 
the expense of these supplements. 
Another approach for inhibition of apoptosis is to supplement with additives 
that can block events within the apoptosis cascade. The addition of the caspase 
inhibitors (Ac-DEVD-cho and z-VAD-fmk) suppresses the apoptotic program in 
hybridoma cells deprived of glutamine[67]. However, Caspase inhibition does not 
appear to provide complete cytoprotection from the apoptotic process because 
mitochondrial dysfunction, phosphatidylserine exposure, plasma membrane 
permeabilization and loss of clonogenic potential are still observed[68] 
Cell line 
CHO 
CHO 
Hybridoma 
Hybridoma 
Hela 
NSO 
Table 4 Media supplementation in multiple cells 
Manipulation 
Suramin[63] 
Transfenin and insulin like growth factor I receptor [69] 
High mitochondrial membrane potential selection [70] 
Rapamycin [71] 
Silkworm hemolymph [65] 
Hsp70[38, 66] 
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2.3.4.2. Genetic strategies 
Genetic strategies have proven successful in delay apoptosis in mammalian 
cell culture. Over-expression of anti-apoptotic genes towards delaying the onset of 
apoptosis has been attempted in animal cell culture[16, 31]. 
The Bcl-2 was the first to be recognized as an anti-apoptotic gene and protein 
it produces to enhance cellular robustness: in C. elegans, ced-3 and ced-4 were 
identified as genes essential for programmed cell death, while ced-9 was found to be 
a regulator of cell death by preventing apoptosis. The first mammalian homolog for 
ced-3 was described in 1988 as Bcl-2 which is involved in B-celllymphomas[36-37]. 
The bcl-2 proteins are a family of proteins involved in the response to apoptosis. 
Some of these proteins (such as Bcl-2 and Bcl-XL) are anti-apoptotic, while others 
(such as Bad or Bax) are pro-apoptotic [31, 38, 43, 46-47]. The sensitivity of cells to 
apoptotic stimuli can depend on the balance of pro- and anti-apoptotic bcl-2 
proteins. When there is an excess of pro-apoptotic proteins the cells are more 
sensitive to apoptosis, when there is an excess of anti-apoptotic proteins the cells 
will tend to be more resistant. 
In mammalian cell culture, Bcl-2 is the best studied of the anti-apoptotic 
genes, since it is demonstrated to suppress apoptosis in a wide range of cell types in 
response to numerous inducing agents, including growth factor withdrawal, 
cytotoxic drugs, and exposure to ionizing radiation[72].Bcl-2 resides on the 
cytoplasmic face of the mitochondrial outer membrane, the nuclear envelop, and the 
endoplasmic reticulum. There are a number of theories concerning how the Bcl-2 
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gene family exerts their pro- or anti-apoptotic effect. An important one states that 
this is achieved by activation or inactivation of an inner mitochondrial permeability 
transition pore, which is involved in the regulation of matrix Ca2+, pH, and voltage. It 
is also thought that some Bel-2 family proteins can induce or inhibit the release of 
cytochrome c in to the cytosol which, once there, activates caspase-9 and caspase-3, 
leading to apoptosis[36-37]. This interaction between pro- and anti-apoptotic 
proteins disrupts the normal function of the anti-apoptotic Bcl-2 proteins and can 
lead to the formation of pores in the mitochondria and the release of cytochrome C 
and other pro-apoptotic molecules from the intermembrane space. This in turn 
leads to the formation of the apoptosome and the activation of the caspase cascade. 
Except Bcl-2, other two anti-apoptosis proteins (Bel-XL and XIAP) have also been 
compared with their wild type counterparts and show remarked effects on cell 
viability. 
2.3.5. Methods of apoptosis Detection 
Rapid and accurate apoptosis assay is essential requirements in our research. 
Cell death typically follows one of two distinct paths, apoptosis or necrosis. Cells 
undergoing apoptosis display distinct morphological and biochemical changes. Just 
because of these characteristics, apoptotic cells can be distinguished from healthy 
and necrotic cells. Thus, based on these changes, such as morphological changes, 
DNA fragmentation, exposure of phosphatidylerine (PS) at the outer plasma 
membrane and caspase activation, detection techniques were developed. Normally, 
apoptosis is analyzed either by flow cytometry or fluorescence microscopy. 
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During apoptosis, mitochondria are well preserved; however, nuclei have 
chromatin condensation. On the other side, during necrosis, cells undergo swollen 
mitochondria and nuclear flocculation. These differences among viable, apoptotic 
and necrotic cells can be detected some morphological assessment methods: 
1) Morphological Assessment of Apoptosis: One of the classic features of 
apoptosis is the cleavage of the DNA into fragments. So much work has 
been performed on the analysis of apoptotic events on DNA 
fragmentation. However, DNA fragmentation also occurs in certain 
stages of necrosis [73], and this is not a definitive test for apoptotic cell 
death. Nevertheless, it is a useful feature in characterizing the cell death 
in any case. 
2) Detection of DNA Fragmentation: This phenomenon is easily visualized 
by agarose gel electrophoresis. This method is often tedious and time-
consuming and provides qualitative rather than quantitative data.[74] 
Quantification of DNA fragmentation can be done by labeling DNA (FACS 
analysis) or DNA ends (TUNEL). 
3) Biochemical Analysis of Apoptosis: During apoptosis, members of 
caspases are activated and then orchestrate the apoptotic events. 
Assessment of caspase activation is a good tool that can be applied to 
analyze a variety of apoptotic systems[75]. 
Short comparisons and comments are listed in Table 5 as follows: 
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3.3 
Table 5 Methods for Detection of Apoptosis 
Method Convenience Notes 
Morphological Assessment of Apoptosis 
AO/EB staining[76] Very rapid 
Cannot be stored 
Hoechst 33258 staining Very rapid 
[77] Cannot be stored 
Electron microscopy[76] Expensive and time-consuming 
Annexin V [77] 
Gel electrophoresis [74] 
TUNEL [73] 
Rapid, simple and cell can be 
fixed 
DNA Fragmentation 
Fairly rapid and cheap 
Often used 
Expensive and time-consuming 
Gives information on early vs. 
late apoptosis, necrosis 
Somewhat subjective but 
definitive 
Somewhat subjective but 
definitive 
Definitive 
Only small area can be observed 
Measures an event of known 
significance 
Not all cells expose PS prior to 
loss of membrane integrity 
Hard differentiation between 
bate apoptosis and necrosis 
Qualitative 
Can not define apoptosis exactly 
Does not occur in some cells 
Quantitative and sensitive 
Somewhat definitive 
False-positive 
necrotic cells 
staining of 
Biochemical Analysis of Apoptosis 
Caspase activation [75] Expensive Allows identification of specific 
caspases activated 
All the methods were developed in 1990's, and each method has its 
advantages and disadvantages. At present, TUNEL and Annexin V are commonly in 
use, because both TUNEL and Annexin V methods are sensitive and specific and 
produced similar data in all measurements. Among them, the TUNEL method 
appears to be the most specific method. Annexin V method is limited only by 
successive loss of membrane integrity of the apoptotic cells. Only staining by 
Annexin V cannot distinguish between apoptotic cells and cells that suffered from 
accidental cell death[78]. It needs double stain technique to improve the ability to 
distinguish different cell stages. For double-labeling, Annexin V /PI and Annexin 
V janti-Lamin B2 are recommended [79-80]. On the other hand, using the Annexin V 
method in suspension systems, the number of apoptotic cells can be detected in a 
relatively fast, simple and sensitive way [79]. As far as AO /EB staining method, this 
method can give information on early vs. late apoptosis. This is a very fast method 
comparing to other assays. However, since we need to distinguish not only the 
colors but also the morphological criteria, it is somewhat more subjective than 
TUNEL and Annexin V methods. Normally, this method has been the dye of choice 
for many years for many researchers, and currently it is preferred to combine 
AO/EB staining with Annexin V or TUNEL together to detect apoptosis qualitatively 
and quantitatively. 
AnnexinV 
In healthy cells, the phospholipids of the plasma membrane are distributed 
asymmetrically over the two leaflets of the bilayer. Phosphatidylcholine and 
sphingomyelin are predominant in the outer membrane and phosphatidylerine (PS) 
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is in the inner membrane leaflet. In the early apoptotic stage, PS is externalized to 
the outer membrane. Surface exposed PS can be detected by its affinity for Annexin 
V, which is a phospholipid binding protein. As showed in figure 7 [78], hapten-
labeled Annexin V binds in the presence of millimolar Ca2+ toPS residues that are 
exposed in the outer membrane of apoptotic cells. As far as dead cells, since the 
integrity of the plasma membrane is lost, Annexin V can also bind PS in the inner 
membrane. To distinguish dead and apoptotic cells, Propidium Iodide (PI), a 
membrane impermeable DNA stain, is added at the same time. Thus, viable, 
apoptotic and dead cells can be distinguished bye the double labeling for Annexin V 
and PI, which can be detected by flow cytometry or fluorescence microscopy. Thus, 
this method can be used to distinguish between viable cells (Annexin V-/PI-), early 
apoptotic cells (Annexin V+/PI-), late apoptoticjsecondary necrotic cells (Annexin 
V+/PI+ ), and necrotic cells (Annexin V-/PI+) (Figure 8). 
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Figure 7 Schematic representation of the loss of membrane lipid asymmetry 
during apoptosis[79] 
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Figure 8 Bivariate PI/ Annexin V analysis of rat thymocyte cells. Region Rt 
contains viable cell population (Annexin V-/PI-), R2 contains the early 
apoptotic cells (Annexin V+/PI-), R3 contains late apoptotic cells (Annexin 
V+/PI+) and R4 is necrotic cells (Annexin V-/PI+)[79] 
TUNEL 
Terminal uridine deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) is a common method for detecting DNA fragmentation that results from 
apoptotic signaling cascades. The assay relies on the presence of nicks in the DNA 
which can be identified by terminal deoxynucleotidyl transferase, an enzyme that 
will catalyze the addition of dUTPs that are secondarily labeled with a marker. The 
biotin-labeled cleavage sites are then detected by reaction with HRP conjugated 
streptavidin and visualized by DAB showing brown color. Recently, more methods 
for the detection of apoptotic cells and specific parts of the apoptotic pathway are 
also available such as the detection of caspase activity (specifically caspase-3), Fas-
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ligand and Annexin V, etc. It is also important to use TUNEL in conjunction with 
other methods especially morphology, immunohistochemistry and electron 
microscopy. 
Figure 9 TUNEL staining of formalin fixed, paraffin embedded skin. Note 
nuclear staining of apoptosis cells (green). Counterstain-PI (red) 
2.4. Cell Separation 
Cell separation, which obtains defined cell populations or isolate rare cell 
types to high purity, plays a major role in a variety of biological and biomedical 
applications. The history of cell separation can be tracked back to 1960s. Isolation of 
cell subpopulations has been a major goal in the research on cell biology, disease 
diagnostics, therapeutics and as well as industrial application. The potential 
applications of cell separation can be divided into: removal of specific cell types; 
purification of cell mixtures for diagnostic tests; tracking tumor cells in the body; 
isolation and detection of various cells[81]. 
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Table 6 Methods of cell separation 
Principle 
Density 
Density 
Density, cell size 
Cell shape, surface 
properties 
Using physical properties 
Technique 
Ficoll-Paque density 
gradient medium 
Percoll density 
Elutriation 
Aqueous Two Phase 
Systems (ATPSs) 
Application 
Isolation of mononuclear 
cells from blood 
Removal of dead cells 
Fractionation of 
leukocyte substes 
Separation of cells 
according to their cell 
cycle 
Isolation of 
hematopoietic cells, 
Separation of viable cells 
Using immunological parameters 
Cell-cell interaction Rosseting Depletion of specific 
antibody-mediated leukocyte subsets 
Specific lysis of antibody Complement lysis Depletion of an specific 
coated cells cell type 
Antibody specificity, Fluorescence activated Fluorescent dyes to 
fluorescence cell sorting (FACS) specific cellular target or 
antibodies 
Antibody specificity, Magnetic activated cell Applicable to any cell 
magnetism sorting (MACS) suspension with known 
specific surface markers. 
The current cell separation methodologies can be divided into two main 
groups. The first is based on physical criteria like size, shape and density differences 
using filtration and centrifugation techniques. Another technique comprises of 
38 
affinity methods that are based on biochemical cell surface characteristics and 
biophysical criteria[82-83]. Cell separation technologies can be cataloged according 
to their separation principle. Those include cell separation based on physical 
principles, biological characteristics, biochemical characteristics or a combination of 
one of more of the above. Table 6 summarizes some of the current techniques used 
in cell separation. 
Because oft specificity and high affinity of antibody-antigen interaction, 
usually more purified cell population is expected from the immunological 
separation. At the same time, the cost associated with immunological separation is 
usually higher compared to other physical separation methods. 
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2.4.1. Aqueous Two Phase Systems (ATPSs) 
An aqueous two phase system (ATPS) essentially consists of two immiscible 
aqueous solutions of different polymers. Generally, ATPSs are formed by the 
incompatibility of two aqueous polymer solutions such as polyethylene glycol (PEG) 
and dextran, or one polymer and one low molecular weight solute, such as 
potassium phosphate. ATPSs have been used for the isolation and characterization 
of different types of cells, which is conventional technique and can separate cells 
easily and effectively without using antibodies. It is well known extraction technique 
for the separation of fragile biomaterials such as proteins, biological membranes, 
and cells[84]. Separation is dependent on the properties of the polymers, additives, 
pH and temperature. The basis of cell separation in A TPSs is the selective 
distribution of substances between the two phases due to the sensitivity to cell 
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surface properties such as surface charge and lipid composition, and the presence of 
specific components depending on the cell type. ATPS is one of the few techniques 
that separate cells on the basis of surface properties[85]. The partition coefficient K 
of a cell in an ATPS can be described as K = Crop { and be expressed as a 
/Cbottom 
function of several variables in an empirical formula 
InK= In Ko +In KelectrochiiTlical +In Khydrophobt +InK Biospecifr +In Ksize + ··· 
where KO includes other surrounding environmental factors. This formula 
considers the contributions are both from the cell properties and from the ATPS 
physical conditions[86]. 
Haematopoietic cells were first separated and characterized by ATPSs. 
Walter[87] studied the effects of the relative percentages ofphosphatidylcholine 
and sphingomyelin of the cellular membrane on the partition coefficient and 
showed the importance of membrane lipid composition on erythrocyte cell 
separation. Recently micro fluidic devices were used to separate animal and human 
blood cells continuously[88-89]. Continuous cell partitioning in microfluidic devices 
can create a stable aqueous two phase laminar flow and large interface to perform 
partitioning, without diffusive mixing. Viable and dead CHO-Kl cells were 
successfully separated by this continuous flow extraction method with high purity. 
2.4.2. Magnetic Activated Cell Sorting (MACS) 
Magnetic cell separation is a widely used method for isolating many different 
types of cells, which uses magnetic particles conjugated to proteins or antibodies to 
tag cells of interest Compared with F ACS, magnetic cell separation is based on the 
difference in cell's magnetism between target cells and other cells in the mixture. To 
differentiate cells in their magnetism, target cells are labeled specifically with 
magnetic labels via antibody-antigen interaction or other bioaffinity interactions. 
The specific cells to be sorted are labeled with antibodies to the cell surface antigen. 
Cell mixture containing labeled and non-labeled cells pass a column with magnetic 
field. The magnetically labeled cells are retained on the column, while unlabeled 
cells pass through. These cells can be collected as the unlabeled fraction. The 
retained cells are eluted from the column after removal from the magnet there is no 
harsh physical and chemical treatment required to obtain the targeted cells, which 
are suitable for the further use. They separate cells based on the distances they 
travel under the magnetic energy gradient, which are directly related to the cell's 
magnetism after labeling. These systems can provide higher or comparable 
throughput compared to FACS. Figure 10 shows schematic flowchart ofMACS. 
To label cells, many types of magnetic micro beads and nanobead have been 
developed. Dynaead magnetic particles (Invitrogen, Carlsbad, CA) and MicroBeads 
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) are commercially used. 
Dynabeads were the first magnetic particles used for clinical cell separation 
applications, in particular, bone marrow purging of gliomas prior to 
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transplantation[90]. Due to their relatively large size (from 1 mm to 4.5 mm) the 
preferred applications of Dynabeads is negative cell selection, where the cells 
targeted by the magnetic label are discarded, and only the unlabeled cells are used 
In comparison to micrometer-sized magnetic particles, the use of colloidal magnetic 
particles as labeling reagents offers advantages in forming stable suspensions and 
fast reaction kinetics, similar to immunofluorescence labels and positive cell 
selection. Small magnetic particles (MACS), with diameters ranging from 50 nm to 
150 nm, produce a paramagnetic moment and therefore require the use of high-
gradient magnetic separation fields, such as those produced by thin wires of a 
ferromagnetic material immersed in the cell suspension. [91] 
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Figure 10 Schematic flowchart of MACS using Micro Beads, MACS columns, and 
MACS separators. A mixture of magnetically labeled and unlabeled cells is 
loaded onto a ferromagnetic matrix. Magnetized cells are retained on the 
column while unlabeled cells pass through. Labeled cells are recovered after 
demagnetization of the column. 
Magnetic micro beads coupled with the use of specific antibodies can 
effectively separate cells. Therefore, the successful application ofMACS relies 
mainly on the selection of specific antibody and an appropriate labeling strategy. 
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Based on the antibody used, there are multiple applications for the MACS 
technology such as sperm improvement[92], cancer cell detection[93] and rare cell 
selection[94] 
2.5. Metabolic Flux Analysis of Mammalian Cells 
2.5.1. Introduction 
Metabolic flux analysis (MFA) has become a standard tool for analyzing 
metabolism and optimizing bioprocesses. It uses a metabolic reaction network in 
combination with extra cellular measurements and mass balance to calculate flux 
distributions in metabolism[95]. 
As mentioned previously, the metabolism of mammalian cells is very 
complex. These metabolic pathways determine the fate of any carbon and nitrogen 
sources in mammalian cells under different environmental or genetic background. 
However, their metabolism takes place not only in cytosol but also in mitochondria. 
Also the cells require a complex medium. MFA can be a useful tool to reduce these 
complexities and get a better understanding of mammalian cells[96]. 
MFA is a popular tool for the modeling of metabolic networks containing 
metabolites and reactions. The metabolites are the network nodes and the 
metabolic reactions represent the edges of the network. With the help of a metabolic 
network and the flux measurements, it is possible to find the values of the fluxes. 
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Most studies on MFA use the stoichiometric approach or the isotope tracer 
approach to estimate intracellular fluxes: conventional metabolic flux analysis (c-
MFA) or labeling-based metabolic flux analysis (I-MFA). The metabolic fluxes are 
computed by analysis of nutrient and metabolite levels or isotopic tracer 
concentrations. 
2.5.2. c-MFA 
c-MFA uses the information obtained from determination of measurable 
fluxes and a steady state assumption for the intracellular metabolites to calculate 
the metabolic fluxes in a given metabolic network[97]. Thus the first step is the 
development of stoichiometric model of the metabolic network. Next mass balances 
are written for all compounds present in the metabolic network as follows: 
dX met ,.v ~ = r met - f-U'- met (1) 
Where X met is the concentration vector of the metabolites, rmer is the 
production rate and 11 is the specific growth rate of cells at timet. assuming no 
accumulation of intracellular metabolites, that is the metabolites are at a pseudo-
steady state, the left side of equation (1) becomes zero. Also, since the concentration 
of the intracellular metabolites is very low, JiX mer can be neglected and equation (1) 
can be simplified to 
(2) 
-------- ------------------------
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The rate of formation and consumption of a metabolite is determined by the 
stoichiometric reaction network and the fluxes through each reaction. Supposing 
there are J reactions and K metabolites, the rate of formation of the ith metabolite is 
given by: 
(3) 
where aij is the stoichiometric coefficient of the ith metabolite in the jth 
reaction, and v j is the rate of the jth reaction. Then equation (3) can be written in 
matrix notation as follows 
(4) 
where GT is the matrix of stoichiometric coefficients. Further, we have 
(5) 
The matrix GT and the rate vector v can be divided into two parts: the 
extracellular measured parts ( G m and v m) and the calculated parts ( G c and v c ). 
Then equation (5) can be constructed to : 
(6) 
Calculate v c and get: 
(7) 
-------------------
Equation (7) is for the matrix G'{ invertible, that is the system should be 
exactly determined. If not, a pseudo-inverse of the matrix G~ will be replaced by: 
(8) 
Then v c can then be calculated as follows: 
(9) 
This equation is for the system is redundant and singular[97]. 
However, c-MFA requires an identified metabolic network. This requires 
detailed knowledge, on which enzymes may be expressed, the reactions they 
catalyze and even their localization in cells. This will result in very large networks. 
To simplify this network, serial reactions in linear pathways can be lumped into a 
single overall reaction and biomass components which have the same biosynthetic 
pathway can be lumped into a single component with an average composition. This 
simplification might lead to identifiability of fluxes and c-MFA might be used. 
2.5.3. Identifiability of fluxes 
One of the important issues using MFA to solve the system of equations for 
calculating unknown fluxes should be identifiable. As discussed in above 
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paragraphs, this equation has a solution only if the system is exactly determined, If it 
has full rank, which means rank of this matrix is equal to the number of metabolite 
balances, this condition could be easily evaluated by calculating the rank of the 
matrix, and if it is equal to the number of balances, the matrix is invertible. 
Calculation of rank of matrix G~ helps in identifYing any redundant equations in the 
system of reactions and removing such equations from the system helps in solving 
it. However, in some cases, an analysis of the reaction network may show that some 
of the balances are redundant and this system is underdetermined, then it is solved 
by applying constraints and optimization routines. Thus, reducing the complexity of 
reaction network by lumping some of the reaction or removing them, might lead to 
identifiability of fluxes, facilitating c-MFA analysis. 
2.5.4. Consistency of data 
Since MFA is a very useful tool in the decision making for the cellular 
pathway manipulation or for the studying cellular physiology, it is noted that the 
importance of confidence on MFA results obtained from this analysis. It depends on 
the accuracy of the model being used to calculate the fluxes for intracellular 
metabolites as well as on the extracellular measurements. Therefore, other type of 
balances such as elemental balances can be used to check the consistency of the 
data. One of the popular elemental balances is around carbon, where number of 
carbon atoms going into the system through substrate is balanced against the 
number of carbon atoms coming through the extracellular products. But similar 
information is often not available about the carbon atoms going into the biomass 
and hence it is very difficult to perform accurate carbon balances. Same arguments 
cam also be made for other elemental balances such as nitrogen, oxygen, sulfur and 
hydrogen. Another method, which can be used to check the consistency of the data, 
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is the redox balance analysis. In this case, sum of the multiplications of the products 
moles into their oxidation states should be equal to the multiplication of moles of 
substrate into its oxidation state. 
2.5.5. Sensitivity Analysis 
The sensitivity analysis is performed to provide a certain confidence of 
interval for each flux parameter based on the measurement errors and ensure that 
the stoichiometric metrix developed is well posed. It can be checked by condition 
number and solution matrix. 
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Chapter 3 
Materials and Methods 
3.1. Cell Culture 
The cell line CHO TF 70R that produces tPA was kindly provided by Professor 
Claudia Altamirano (Pontificia Universidad Cat6lica de Valparaiso, Chile) 
Recombinant CHO TF 70R was original from CHO DG 44, which is a dihydrofolate 
reductase-deficient( dhfr-) cell line, by transferring a DHFR( + )-tPA plasmid. T75 
flasks (Corning, USA) were used for the preliminary work for subculture. Seed was 
prepared in a proprietary serum-free medium HyClone SFM4CHO (Thermo 
Scientific, UT). The medium was supplemented with 20 mmol of glucose and 6 mmol 
of glutamate. The cell culture experiments were selected cells from the mid 
exponential phase of growth at a cell concentration of 106 cells/mi. Cell culture 
experiments with selected medium were carried out in spinner flasks (Techne, NY) 
with working volume of 100mL and stirred at SOrpm in a COz incubator at 37°C and 
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5 % COz. During the incubation period, about 600J1.l samples were taken on time for 
analysis. 
The cells for cryopreservation were chosen in exponential growth phase with 
viability above 90%. The cells were centrifuged at 1000g for 5 minutes and the 
supernatant was removed. The cells with the concentration of about 8x106 cellsfml 
were then resuspended in 80% DMEM/F12 medium, 10% serum and 10% dimethyl 
sulfoxide (DMSO). The cells were transferred to 2 ml sterile cryovials (Nalge Nunc, 
NY) freezing container. The container was kept at -80 oc overnight and then transfer 
to the liquid nitrogen tank with the model ofXC33/22 (CBS, Ml) for long term 
cryopreservation. 
3.2. Analytical Methods 
3.2.1. Determination of Cell Density and Viability 
Cell number was estimated using a hemacytometer (Neubauer improved, 
Hausser Scientific, PA) and counting was under a normal light inverted microscope 
(AE 31, Matic, Canada). Cell viability was determined through the method ofTrypan 
Blue Exclusion. The trypan blue exclusion method was outlined by Patterson. Viable 
cells with membranes will exclude trypan blue. Cell sample was removed from cell 
suspension. An equivalent volume of0.2% Trypan blue (1:1 mixture ofTrypan Blue 
Solution (0.4%) (Sigma, MO) and PBS buffer (vfv)) was added to the cell sample. 
Cell/Trypan mixture was mixed by pipet gently for approximately 10 times. Allow to 
stand for 1 to 2 minutes at room temperature to permit dye uptake. The stained 
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sample (about 15mL) was transpired onto a hemacytometer. The total number of 
cells and the number of unstained cells were counted under the inverted 
microscope (10 X objective) in all of the ( 4+4) of the major sections of the counting 
chamber (1mm x 1mm). Viable cells and cells in early stages of apoptosis exclude 
trypan blue; cells in the late stages of apoptosis and necrotic cells take up the dye 
and appear as blue cells[1]. 
The counting rule was: count all the cell in the 1mm2 squares of A, B, C and D 
and delete both the maximum and minimum of viable cells and non-viable cells. Sum 
the two rest numbers of viable cells and get the total viable cells. Sum the two rest 
numbers of non-viable cells and get the total non-viable cells. 
The formula to derive the concentration of cell sample was: 
c= n lmm3 l000mLx 2 =nxl04(celz;{, ) 
2lmmxlmmx0.l0mm lmm3 mL 
(10) 
where cis the cell concentration (cells/mL) and n is the number of cells 
counted. (Note: the first 2 in the denominator is 2 squares of counting areas we sum, 
and the second 2 in the numerator is we dilute cell sample by equivalent volume of 
trypan blue solution). The average of two counts was used as the calculating result, 
and the percentage of viable cells and total cells was used to calculate the cell 
viability. 
Specific cell growth rate (!l), specific nutriments consumption rates, specific 
byproduct rates and tPA production rate are estimated by plotting the 
concentrations of total cell, nutriments consumption, byproducts and tPA versus the 
integral of viable cells (IVC). 
3.2.2. Metabolite determinations 
3.2.2.1. Analysis of sample composition using HPLC 
Metabolite composition of the samples was mostly measured by HPLC (high 
performance liquid chromatography) such as glucose, lactate and amino acids. At 
each measurement point, samples were drawn from the spinner flask and were 
centrifuged as described previously and store at -20 Q(. VP series HPLC system by 
Shimadzu Scientific Instruments (Columbia, MD) was used in our study. The data 
was analyzed by the software, VP Class developed by Shimadzu, for calculating area 
under the peak for each compound. 
Sugars and lactate 
Samples were run through the organic acid column Aminex HPX-87H from 
Bio-Rad Laboratories (Hercules, CA) under optimum conditions determined by the 
optimization routine developed from our group for effective separation of glucose 
and lactate. Deionized water for the mobile phase and needle wash was purified 
using a Nanopure II system (Barnstead, Dubuque, lA) to a conductivity of 18 MQ-cm 
and filtered through a 0.2211 membrane (Millipore, Billerica, MA). !socratic elution 
for all runs was executed at flow rate = 0.3 mljmin using 5 mM HzS04 solutions as 
mobile phase at column temperature 42 oq98]. 
Amino acids 
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Amino acids were analyzed via a reversed phase HPLC with pre-column 
derivatization by orthophthalaldehyde (OPA). Samples were centrifuged at 1000g 
for 5 minute to remove the cells and the supernatant was filtered through a 0.221-1 
membrane. The prepared samples were sent to Medical Genetics Laboratory at 
Baylor College of Medical (Houston, TX) for further analysis. 
3.2.2.2 Glucose Uptake assay 
Cells were plated at 5x105 cells/well in 24-well plates with various 
concentrations of2-NBDG (10-801J.M). After incubation in at 37°C and 5% C02 for a 
certain period of time as described in each experiment, the 2-NBDG uptake reaction 
is stopped by removing the incubation. After centrifugation, samples (1x105 cells) 
were washed with ice-cold PBS buffer and then diluted with 5001J.l of buffer to the 
final analysis solution. Samples were analyzed in a FACSCanto II (BD Biosciences, 
San Jose, CA) with 10,000 cells counted per event. 2-NBDG shows intense 
fluorescence at 542nm when excited at 46 7nm. 
3.2.3. Protein sample preparation 
Samples are collected from spinning flasks. Cell pellets are centrifuged at 
1000g for 10 minutes and are washed by ice cold PBS twice and then stored at-
80°C. When preparing protein extracts, frozen cell pellets are thawed and 
resuspended in lysis buffer containing 7 M urea, 2M thiourea, 30mM Tris-Cl, 5mM 
magnesium acetate, 4% 3-[(3-Cholamidopropyl) dimethylammonio]-1-
propanesulfonate (CHAPS) with the amount about 1 ml per 5 X 107 cells [99-102]. 
The mixture is homogenized carefully by 20 gauge needle five times. Samples are 
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left on a plate shaker at room temperature for 1 hour to allow extraction and then 
centrifuged at 14000 rpm at room temperature for 15 minutes. The supernatant is 
removed and samples are stored at -80 ·c for use. Concentrated proteins are 
resuspended in the DIGE labeling buffer (8M urea, 4% w jv CHAPS, 30mM Tris pH 
8.0) and concentration is measured by Bradford protein assay (Bio-Rad, UK).[103] 
3.3. Quantification of Apoptosis 
Apoptosis will be evaluated by the CytoGLO™ Annexin V -FITC Apoptosis 
Detection Kit (IMGENEX Co., CA). One hundred 111 of samples at a concentration of 
106 cellsjml are washed twice with 1000111 of PBS (pH 7.4) and then resuspended 
by 100 flL of binding buffer (10mM Heps/NaOH, 140mM NaCl, 2.5 mM CaC12, pH 
7.4). The reaction solution is added with Sfll of Annexin V-FITC and Sfll of PI and is 
incubated at room temperature in the dark for 15 minutes. 
3.3.1. Imaging study 
After incubation, the stained sample (about 15!11) was transpired onto a 
hemacytometer (Neubauer improved, Hausser Scientific, PA) for observation. 
Samples were observed by fluorescence microscope with lOx, 20x, 40x objectives 
(Olympus, San Jose, CA). Images are taken and determined numerically using 
Compix Imaging software (Hamamatsu Photonics Management Co, Sewickly, PA). 
The images captured were gray-scale images and needed to be processed to colorize 
via software Image-J (National Institutes of Health, USA). 
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3.3.2. FACS analysis 
For FACS analysis, samples are diluted with 400!!1 of binding buffer to the 
final analysis solution. Samples should be analyzed as soon as possible within 1 
hour, since apoptosis is a rapid and dynamic process. Samples are analyzed via BD 
FACSCanto II (BD Biosciences, San Jose, CA), and the instrument settings is as 
follows: FSC= 275, SSC= 359, FITC: FL1=381, PI: FL2=391; Threshold FSC 15000; 
Compensation: PI to FITC: 0; FITC to PI: 0.53. The data are evaluated using the 
software FACSDiVa 6.2. 
3.4. Cell Separation 
3.4.1. Aqueous Two-Phase Partition System (ATPS) 
10% (wfw) Dextran TSOO and 8% Polyethylene glycol8000 (PEG 8000) in 
10mM sodium-potassium phosphate buffer at pH 7.4 were prepared as stock 
solutions. Phase systems were prepared by weight (1:1) from the stock solutions. 
The systems must be mixed well, left in a separatory funnel for 6 hours to 
equilibrate at room temperature. Samples with total cell number at approximate 108 
were washed twice with 10ml of PBS (pH 7.4) and then resuspended with 50 ml of 
working phase solution. After around 30 minutes of setting. 70!!1 of result samples 
in each phase were collected for apoptosis and viability assay. 
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3.4.2. Magnetic Associated Cell Sorting (MACS) 
Magnetic cell isolation uses MiniMACS kit (Miltenyi Biotec, Bergisch 
gladbach, Germany). The samples are centrifuged at 150g for 5 minutes at 37·c and 
the cells collected are washed twice by PBS buffer (pH 7.4). The cell pellets are 
resuspended by 80!J.l of binding buffer and 20111 ofMACS Annexin V MicroBeads per 
107 total cells. The suspension is mixed well and incubated for 15 minutes at S"C. 
After incubation, the suspension is passed through MS column kept in magnetic 
field. The column is washed with the equal volume of buffer three times. The 
unlabeled cells passing through in the effluent are collected. Then the magnetic field 
is removed. Equal volume of buffer is applied onto the MS column to flush the 
labeled cells out. Also, the column is washed with the equal volume of buffer three 
times to remove the remaining labeled cells. 
3.4.3. Ficoll gradient centrifugation 
Samples were diluted by 4x PBS buffer. Each 35mL of diluted cell suspension 
was carefully layered over 15mL ofFicoll-Paque Plus (GE healthcare, NJ), drop by 
drop. Mixture was centrifuged at 400xg for 30 minutes at 20QC in the swinging 
bucket rotor without brake. After centrifuge, the upper layer was aspirated and the 
target cells at the interphase were obtained. 
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3.5. Metabolic Flux Analysis 
From the experimental data of extracellular concentrations, the 
stoichiometric model described in appendix was divided into measured ( G~) and 
calculated (GJ) matrices and the intracellular fluxes (vc) were calculated from 
measured fluxes Cvm) using equation in chapter 2. 
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Chapter 4 
Investigation into Cell Growth and 
Apoptosis 
4.1. Introduction 
Cell death via apoptosis is an essential process in the life of mammalian cells 
in serum-free batch culture[32, 54]. Although cell cultures are sometimes treated as 
a homogeneous mixture of identical cells, cell heterogeneity almost undoubtedly 
exists within cell culture system. The fact is that individual cells exhibit 
heterogeneity as a result of small differences in their cellular metabolism dynamics. 
Throughout the course of a cell culture cycle, cells run the risk of encountering 
numerous stresses or insults and each individual cell may or may not commit 
apoptosis. 
From an industrial point of view, the goal of study on apoptosis during cell 
growth is to prolong cell growth as much as possible in the cultivation, thus giving a 
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higher concentration of targeted protein. Classical descriptions of cell growth rarely 
include death via apoptosis, but only viability. In the research of cell culture, Trypan 
blue dye exclusion test was normally applied to characterize the total population of 
cells as either viable or dead. However, this is just a rough description to distinguish 
cell stages, moribund through apoptosis. In order to improve our understanding of 
apoptosis in mammalian cell culture, specific cell phases during culture need to be 
detected and characterized. The changes from these phases such as apoptotic and 
non-apoptotic, should bring more information of apoptosis, which can help us better 
understand this process. 
Our research is conducted in an effort to understand cultured mammalian 
cell behavior. So, it is imperative to identify healthy and apoptotic cells during cell 
culture using prior knowledge and current techniques. The method of apoptosis 
assay using dual staining with Annexin V-FITC and PI can distinguish viable non-
apoptotic cells, early phase, late phase of apoptotic cells and necrotic cells based on 
membrane integrity and DNA fragmentation[104]. Each stage of the cell life cycle 
exhibits characteristic morphology. It has been documented that cell morphology 
may be used to infer the cell status. Flow cytometry and fluorescence microscopy 
can be used to detect several of the morphological changes characteristic of 
apoptotic cells. In particular, flow cytomery can be used to calculate the percentage 
of apoptotic cells present in a cell population and fluorescence microscopy can 
describe briefly the different morphological features of cell undergoing apoptosis. 
Fluorescence imaging provides the means of identifying the different stages of cell 
growth and death(lOS]. To fully understand apoptosis, one should investigate not 
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only at single cell level, but also at the population level to compare the percentage of 
apoptotic cells within the population. Due to the capacity to analyze and isolate 
simultaneously a large number of singe cells for different parameters and 
requirements, FACS has changed our understanding of the behavior of cells in 
culture. Investigation into apoptosis during the course of a cell culture cycle can 
help us provide the checkpoints for the future research. 
4.2. Results 
4.2.1. Investigation into Cell Growth Characteristics 
Both kinetics of cell growth and metabolism are desired for a better 
understanding of cell physiology and program of apoptosis. For these reasons, the 
first consideration was to describe the kinetics of CHO cell growth. Growth 
characteristics ofCHO cell culture had been studied in batch culture. Spinner flasks 
with SOmL working volume were used in this small-scale culture system to describe 
the time profile of the concentration of cells, nutrients and metabolites. Both the 
viable cell number and the specific growth rate reach a maximum and decline 
afterwards. The cell growth curve in SFM4CHO medium with 20mM glucose and 6 
mM glutamic acid in batch culture is given in Figure 11. Figure 11 shows that the 
growth curve for batch run had been broadly divided into three phases: lag, 
exponential and post exponential. The specific growth rate was f.lavg = 0.6718 I day 
during the exponential phase and maximum specific rate occurred in the late 
exponential growth before cell concentration reached its peak The maximum cell 
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concentration achieved was 4.37x106 cellsjmL, as well as the cells keeping high 
viability (over 90o/o) as determined by Trypan blue dye on day 7. Cell death was also 
minimal during this time. 
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Figure 11 Time courses of viable and dead cell number in batch culture 
To further confirm this observation and quantitatively investigate the cell 
growth behavior, F ACS was applied as a tool to detect and monitor the transition of 
apoptotic cells and estimate subpopulations in batch culture. Cells stained with 
Annexin V-FITC and PI can be distinguished into subpopulation between viable, 
early apoptotic, and late apoptotic, and can help us examine the kinetics of 
apoptosis. Equivalent experiments were performed. During the exponential phase, 
the conditions of growth were more stable, the samples were analyzed every 24 
hours. However, samples were analyzed every 4 hours at the end of exponential 
phase and every 2 hours post exponential phase because apoptosis is a relatively 
fast and dynamics bioprocess [106]. 
In comparison to the samples in exponential growth phase, the Annexin V-
FITC fluorescence was significantly shifted to higher intensities very quickly in the 
post exponential phase. 
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Figure 12 Time courses of early and dead late apoptotic ratios in batch culture 
The results are described in figure 12. Initially, in the lag phase, both the 
early and late apoptotic ratios were higher than those in exponential growth phase 
due to the cell growth adaption. It was noted that apoptotic ratio in lag phase was 
approximately two-fold higher than that in cell growth exponential phase. During 
the lag phase, cells were preparing for reproduction, but no increase in cell number. 
It is possible because that certain amount of cells underwent apoptotic while there 
was no cell growing. Moreover a significant increase of ratio oflate apoptotic cell 
but no increase of death ratio was observed. When cells entered exponential growth 
phase, stable apoptotic rates were found with early apoptotic ratio at (3.61±1.10) o/o 
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and late apoptotic ratio at (3.17±0.81) o/o. The apoptotic ratios and dead ratio were 
compared. A significant apoptotic death was found between day 6 and 7 (144 to 168 
hours) due to the nutrient depletion. Early apoptotic ratio stayed constant up to 
160 hours, while late apoptotic ratio up to 144 hours. But death ratio remained at 
( 4.67±1.59) o/o for more than 168 hours (day 7). It is possible that late apoptotic 
ratio is significantly more sensitive than viability at quantifying cell status. In 
contract, comparison of stabilities between early and late apoptotic ratio from lag to 
exponential growth phase indicates that cells from early to late apoptotic status are 
more sensitive to environmental changes and the active phase of late apoptotic 
might be relatively shorter. With the nutrient depletion, cells tend to display 
exponential apoptotic death ratio. After cell concentration reached its peak, the total 
cell number was supposed to be constant and apoptotic ratios were applied to fit the 
data. The expressions of ~e = ...!:... ddXe and ~1 = ...!:... ddX1 were considered, where ~e and Xvt Xet 
~1 represent the specific apoptotic rates for early and late apoptotic cells 
respectively, and Xv, Xe, and X1 are the viable, early apoptotic and late apoptotic 
population respectively. Specific rates of apoptotic ratios were calculated and the 
experimental data in cell post exponential growth phase were analyzed by nonlinear 
regression. Specific rates of early apoptotic ratio were found to follow exponential 
equation as ~e = ~eoek(t-to), where ~eo is the constant of specific apoptotic rate, t 0 is 
the time point where stable early apoptotic rates are expired, and kis a kinetic 
constant. The calculated result was 
J.le = 0.003el.SG(t-lGO) (R2 = 0.943) 
In contrast, the specific late apoptotic rate did not follow the exponential 
model and instead exhibited a constant at (0.0914±0.0176) hr-1. The calculated 
results are shown in figure 13. 
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Similar calculations were done for the exponential growth phase with the 
consideration of all viable, early apoptotic and late apoptotic cells. The specific early 
apoptotic rate was (0.0324±0.0189) hr-1 and the specific late apoptotic rate was 
(0.0677±0.0221) hr-1, respectively, close to the calculated data above in post 
exponential growth phase. Overall these data well described the kinetic apoptotic 
behavior throughout the course of a cell culture cycle. 
4.2.2. Fluorescence Image 
Images shown in this report were obtained in experiments for batch culture 
in spinning flasks. lOx, 20x, or 40x were used to observe and characterize the 
overall population into viable, early apoptotic, late apoptotic and dead cells for a 
total duration of9-day culture (figure 14 showed the images during and after 
exponential phage (day 3 and day 8)). The cell morphology was observed from day 
2, the late oflag phase. On day 2, in BF (bright filed) image, some cells still lost the 
intact structure, and they did exhibit clearly week green in FTIC, however, they 
exhibited bright red in TXRED. This demonstrated that there were no obvious early 
apoptotic cells, only late apoptotic cells except viable cells. The week green signal 
could be observed under the eyepiece, but hard to be captured by camera due to the 
long exposure time and photo bleaching. This is in good agreement with what we 
measured by FITC, as the late apoptotic ratio was significantly high. From day 2 to 
day 7, during the exponential growth phase, apoptotic cells were observed, but 
viable cells were dominant. On day 3 and 4, most of apoptotic cells were in early 
stage (Annexin V+/PI-) and were still maintaining an intact structure. Also there 
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was visible chromatin condensation in some of the cells with no loss of nuclear 
integrity, which is the typical early apoptotic cell morphology. From day 5, the ratio 
of apoptotic cell to viable cells was increasing sharply and some of the cells 
progressed to the late apoptotic stage where the cellular membrane exhibit 
permeability and stained red by PI as time went on. The trend continued 
subsequently with some cells receding into late apoptotic stage. During the 
observation ofthe whole culture process, the number ofapoptotic death cells 
increased continuously and dominated the total dead cells at the end of the culture. 
As far as PI positive signals, although Annexin V-FITC and non-vital dye PI could not 
allow the discrimination of necrotic cells and debris which are both Annexin 
negative and PI positive, most of the PI positive cells were also Annexin V positive at 
the end of our culture. These results demonstrate that apoptosis is the prevailing 
death mechanism in our cell line and culture conditions. From these trends, it seems 
that the kinetics of transition from early apoptosis to late apoptosis and then to 
dead cells is much faster than the kinetics of apoptosis induction. 
Also fluorescent images taken from experiments indicated that death of the 
CHO cells is primarily through apoptosis, since red stained number were observed 
after green stained number. In exponential growth phase, green stained cells were 
first found and then red ones. That indicates that cell death is via the process from 
viable, early apoptotic, late apoptotic stages and then to apoptotic bodies. 
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Bright Field (left two: viable; right: early 
apoptotic) 
Fluorescent 
Imaging during exponential phase (day 3) 
Bright Field (most of them were in late 
apoptotic stage and lost the intact structures) 
Fluorescent 
Imaging after exponential phase (day 8) 
Figure 14 Imaging of viable, early and late apoptotic cells stained with 
Annexin V-FITC and PI under 40 X objective (fluorescent images were 
enhanced by Adobe Photoshop CS software) 
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4.3. Discussion 
Preliminary data from fluorescence imaging used as a tool to capture the 
changes in cell morphology along the course of batch culture showed the transition 
from healthy to apoptotic cells. This study led to interesting insights into how 
apoptosis is executed at single cell level, but included no population heterogeneity. 
While population measurement emphasizes characterization of overall cell 
population into subpopulations based on differences throughout the course of a cell 
culture cycle, it failed to take into account intracellular details. From this point of 
view, the combination of the fluorescence imaging of single cell and population 
measurement may help us understand apoptosis during cell culture. 
Fluorescence microscope works for our observation as a tool to capture the 
changes in cellular morphology along the course of cell culture. From the images, 
dramatic morphological changes, such as chromatin condensation, structure and 
others were observed. Initially, the integrity of the cell membrane remains intact. 
The organelles inside of viable cells were distributed evenly (Imaging during 
exponential phase in bright field). It began to condense to form aggregates at the 
nuclear periphery in the early apoptotic stage (Imaging during exponential phase in 
bright field). However, in late apoptotic cells, the chromatin further condensed into 
discrete parts, and then formed apoptotic bodies (Imaging after exponential phase 
in bright field). Besides the late apoptotic cells were both Annexin V and PI positive, 
comparison between early and late apoptotic cells in fluorescent field also showed 
that fluorescence intensity oflate apoptotic cells was significantly higher. 
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Concomitant with subcellular alterations during apoptosis, cell underwent 
changes in shape as well as changes in the proximity and spacing of cells within 
colonies. Viable and early apoptotic cells were round and detached to each other. 
However, late apoptotic cells showed irregular shapes as well as clustering status of 
the cell population, indicating significant changes of cell surface during apoptosis. 
Cell attachment is influenced by cell structures, surface charge characteristics, and 
hydrophobicity. As is evident from literature available[107-108], apoptosis makes 
the surface negative charge increased due to the exposure and enrichment of PS on 
the outer surface of the plasma membrane. The cell surface charges of healthy and 
apoptotic cells were measured by Zeta Potential analyzer. Results showed that 
viable cells had surface charge close to neutral (1.1±11.97)mV, while late apoptotic 
cells had surface negative charge (-17.8±7.45)mV. Although it could not express why 
late apoptotic cells adhered together, it showed a significant change of membrane 
during apoptotic. 
By combination Annexin V-FITC with PI staining via F ACS had been found to 
give good correlation with the levels of apoptosis throughout the course of a CHO 
cell culture cycle, during which apoptosis accounted for the major of cell death with 
constant specific apoptotic rates for early and late stage during the cell exponential 
phase. And in the post exponential growth phase, early apoptotic cells generated 
from non-apoptotic cells had an exponential expression on its specific apoptotic 
rate, while cells from early to apoptotic were still following the rate as similar as 
that in cell exponential phase. These findings validated those obtained in the 
fluorescence studies demonstrates that late apoptotic cells are already isolated from 
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the environmental condition and they just follow a certain rate to finish the whole 
apoptotic rate. In contract, early apoptotic cells still keep a relationship to 
environmental condition, indicating that they are still having biological activity. 
On the other hand, since the whole process of apoptosis is too complex and 
many causes can trigger apoptosis in cell culture, only one kind of apoptosis assay 
cannot fulfill the understanding of apoptosis process, it is important to use the 
combination of apoptosis analysis methods. Multiple assays will give us a multi-
dimensional view of apoptosis, by analyzing more than one apoptotic characteristic 
simultaneously. This may be very informative about the nature of the apoptotic 
pathway and may give us convincing confirmation that apoptosis is occurring 
during cell culture. With the availability ofF ACS, we have a wide variety of 
instruments, single and multiple laser, flow and imaging, to observe and 
characterize apoptosis. TUNEL, caspase analysis and DNA ladder will be applied for 
elucidating the complex progression of apoptotic death. It is proposed to use this 
multiple approach to analyzing apoptosis in cell culture to provide information in 
multiple early, intermediate, and late apoptotic stages. 
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Chapter 5 
Apoptotic and Non-apoptotic Cell 
Partition 
5.1. Introduction 
The long-term goal of our studies is to identify metabolic differences 
between apoptotic and healthy cells using functional genomics approaches. In order 
to reduce the effects from a vast number of extracellular factors, we want to observe 
and characterize apoptotic and healthy behavior in the same "natural culture" 
condition. In our work, no extreme conditions but only metabolic stresses will be 
investigated for the aim. In order to obtain the apoptotic cell population from the 
cell culture, different cell separation techniques were used as part of sample 
preparation. Cell separation is increasingly used in biotechnology to isolate a 
specific cell population from a heterogeneous mixture of cells. Magnetic Associated 
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Cell Sorting (MACS) and other systems such as, aqueous Two-Phase Systems 
(ATPSs) and gradient centrifugation were compared. 
MACS developed rapidly in the past decade. The interaction of a cell with a 
magnetic field is usually mediated by a magnetic particle conjugated to antibodies or 
a chemical reagent, which binds specifically with the targeted cell population. F ACS 
provides a method that allows us to analyze quantitatively several fluorescence 
parameters of individuals and purify them. However, what we need is bulk sorting 
for the future analysis. For example, in order to fulfill the requirement of 
proteomics, we would need to separate different samples on the order of 107 cells to 
detect expressed proteins, from a total starting population of -10s harvested cells. 
Even ifwe use a common high-speed cell sorter (BD FACS Vantage SE), which sorts 
cells at rates up to 25,000 cells/second, the translation time is at least 4,000 second. 
This does not take into account cell losses due to sample preparation and handling 
or time losses due to technical issues. Also, cross contamination becomes a problem 
at the highest sorting rate. However, apoptosis is a rapid and dynamic process [106], 
and normally, apoptosis detection using flow cytometer should be completed within 
1 hour after cells are labeled. Moreover, during the sorting process, cells are 
exposed to conditions that might bring about changes in gene and protein 
expression. Preliminary research in our group on cell viability and apoptotic status 
in buffer solutions has shown that all the separation should be finished in 2 hours. 
Therefore, it is important that isolated cells retain their viability and biological 
function after the separation process, which means that traditional F ACS based 
methods do not satisfy our requirements. In order to separate cells, the effective 
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method needs also the drive to separate the targeted cells. Compared to FACS, MACS 
uses magnetic field as force, which is more powerful, efficient and less time-
consuming. Several examples of magnetic separation systems have been reported in 
recent years with good purity (>95%) and high throughput ( -1011 cellsjhour)[82]. 
The selection of healthy and apoptotic cells is a prerequisite for comparing 
different subpopulations. In this study we applied commercially available Annexin-V 
directed against cell surface activation sites for selection of apoptotic cells under 
high throughput conditions. The system consists of a column filled with polymer-
coated steel beads that when placed inside a magnetic field creates a high magnetic 
gradient capable of retaining magnetically labeled cells. Magnetic cell sorting using 
annexin-V micreobeads can effectively separate apoptotic and non-apoptotic cells. 
A previous study by Nam et a/[88] determined the conditions and 
requirements for viable and dead CHO cell partition using ATPSs of PEG 8000 ( 4%) 
and dextran T500 (5%) in 10mM sodium-potassium phosphate buffer. The ability of 
Percoll density gradient centrifugation to remove spermatozoa with PS 
translocation of membrane fraction was studied to select non-apoptotic 
spermatozoa[109] and apoptotic thymocytes were enriched via density gradient 
centrifugation[110]. We then compared different separation technologies to achieve 
separation of apoptotic and non-apoptotic cells. Our results proved that the MACS 
technology surpasses the results achieved by other systems. 
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5.2. Results 
5.2.1. Effect of concentration of binding beads 
The ideal concentration of antibody beads leads to label the target cells 
without or with the least possible unspecific staining of non-target cells. Although 
commercial device MiniMACS system was used, the optimal concentration of 
antibody beads was only designed for the depletion strategy. The concentration of 
magnetic beads depends on the target on the cell surface receptor as well as on the 
affinity of the antibody and a Langmuir type saturation relationship was reported 
when binding the appropriate cell receptor[111 ]. It is important to note that the 
amount of apoptotic surface marker, the exposure of phosphatidylserine (PS), at the 
outer plasma membrane, depends on the apoptotic stages. Considering the classical 
antigen-ligand interaction theory, the amount of binding beads influences the 
separation results. The recommended concentration was 2001J.L/108 total cells. To 
determine the effect of labeling bead concentration, cells stained with four different 
concentrations of magnetic beads were tested: 50, 100, 200, and 400!J.L/107 target 
cells. After labeling, the fluorescence intensities were measured via FACS (only FITC 
intensity was considered). Figure 15 shows the separation performance versus 
labeling bead concentration. 
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Figure 15 MACS separation performance in different labeling bead 
concentrations for samples from stationary phase. 
The same test was applied for samples from exponential growth phase 
(Figure 16). Only the negative selection (non-apoptotic fraction) was considered 
due to the very low apoptotic ratio during exponential growth. The histogram of 
purity did not show obvious differences under each treatment, except the result 
from the test of SO!lL/107 target cells. It has been demonstrated that during 
exponential growth, the average amount of PS externalization is less than that in 
stationary phase, resulting in less binding positions. Saturated binding could then be 
reached using a concentration of magnetic beads of 100!lL/10 7 target cells. 
Comparison between the two figures shows that the binding saturation is related to 
the property of cells and antibody conjugates, not to the relative amount of 
antibodies. 
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Figure 16 MACS separation performance in different labeling bead 
concentrations for samples from exponential growth phase (apoptotic 
deletion only) 
It is important to note that when the labeling bead concentration was too 
high or too low, the results were not good. Too high concentrations of antibody 
beads (400J1L/107 target cells) might lead to unspecific labeling ofnon-apoptotic 
cells. This would reduce the purity of the selected fraction, which led to lower purity 
of apoptotic fraction than the other treatments. Too low concentration of antibody 
beads (SOJ!L/107 target cells) might lead to an insufficient labeling of apoptotic cells, 
resulting in a reduced purity of the annexin negative fraction. Therefore 100 and 
200J1L/107 target cells were regarded as the optimal concentration and were used 
in subsequent experiments (100J1L/10 7 and 200J1L/107 target cells were used for 
samples in exponential growth phase and samples in stationary phase, respectively). 
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5.2.2. Separation performance in different cell status 
Several values are commonly used in evaluating the performance of cell 
separation processes, such as recovery, final purity, enrichment, and throughput 
rate. However, purity and recovery depend on the objective of the separation, the 
starting cell mixture characteristics, and the method used for isolation. To evaluate 
the performance ofMACS, raw cell samples (approximate 2 to 5x107 total cells) 
were carried out from middle and end of growth exponential phase (day 4 and day 
6.5), respectively. Data in Figure 17 are representative flow cytometry plots before 
and after separation. 
No matter whether apoptotic cells were in low (5-10% of all in our tests 
during exponential phase) or high percentage (more than 30% in cell transition 
phase), after separation, the annexin-V negative fraction prepared by MACS had a 
low apoptotic ratio, less than 2% of total cells, while the annexin-V positive fraction, 
which was labeled, was retained in the column. The retained fraction eluted from 
the column after removal of the magnetic field had a rather high apoptotic ratio 
more than 80%, which represents about 10-fold enrichment. Similar sorts have 
been done with the apoptotic ratio at 85% to 97%, depending on the initial 
apoptotic rate and loading amount. Comparing the results of purity in different 
phases, the percentage of healthy cells collected in the annexin negative fraction was 
significantly higher during exponential growth, and less debris was generated 
during passing through the column. However, samples from the transition phase 
between cell growth exponential and stationary phase had high levels of debris in 
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annexin negative fraction after separation due to the mechanical damage caused by 
matrix material during passing through the column. It is possible that this was 
caused by the increased sensitivity to mechanical damage due to nutrient limitation 
in stationary phase. 
Before MACS 
S ecimen 001-d 4 after unlal 
Unlabeled partition after MACS Labeled partition after MACS 
Early apoptotic 
Late apoptotic Q2 Debris Q1 Healthy Q3 
Q4 
Before MACS 90.1°/o 2.4°/o 6.6o/o 1.0°/o 
Unlabeled 98.4°/o 0.2°/o 0.1 o/o 1.3°/o 
labeled 18.0°/o 45.8°/o 36.2°/o 0.1 o/o 
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Before MACS 
001-labeled 1 2 
Unlabeled partition after MACS Labeled partition after MACS 
Healthy Q3 
Early apoptotic 
Late apoptotic Q2 Debris Ql Q4 
Before MACS 68.1o/o 6.7°/o 23.5°/o 1.7o/o 
Unlabeled 88.5o/o 0.6°/o 1.4o/o 9.5°/o 
labeled 2.4°/o 56.9°/o 39.9°/o 0.8o/o 
Figure 17 MACS results 
The recovery of separation was calculated by dividing total number of target 
cells in each fraction by the initial count of cells. In unlabeled partition, the recovery 
(72%) of samples from cell exponentially growing cells was much higher than the 
recovery (53%) from stationary phase samples. It is possible that the debris 
generation led to low recovery. However, in both cases cell recoveries in labeled 
partition are not in good agreement with the expected values, since the overall 
recovery is only around 40%. It is possible that when the magnetic field was 
removed a certain amount oflabeled cells were still retained in the column. A 
modified separation process for labeled fraction with more flush was also tried, but 
still with lower separation recovery. These results suggest that more studies need 
to be done to have a better understanding of the process. 
5.2.3. Effect of mobile phase on cell separation 
As can be found out in the flow cytometry data, a significant population of 
debris still exits after separation. Due to the fact that cells will be easy damaged 
under the condition without nutrients, it is necessary to determine how to protect 
cells from mechanical damage during MACS process. After taking from medium, cells 
will be washed by PBS buffer and be incubated in PBS buffer or binding buffer at 
room temperature or at 4 ·c. Only pH value and osmolarity are close approximations 
to the normal medium without any protective factors. In cell culture technology, 
although serum-free formulations are required and developed in both the research 
and the industrial communities, serum is also used in some tough conditions, such 
as cryopreservation, to protect cell survival. In order to reduce the sensitivity to 
mechanical damage during cell separation through the column and minimize the 
debris in annexin negative fraction, serum was tested because serum can protect 
cells from shear induced by mechanical agitation[llO]. Cell separation was carried 
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out using two different mobile buffers during passing the columns. Samples were 
collected in stationary phase. Using the optimized operating conditions for the first 
steps and after incubation with magnetic beads, binding buffer and medium with 
10°/o serum were used as mobile phase to elute the column, respectively. 
Elute using binding buffer Elute using medium+ 10°/o serum 
(a) 
Elute using binding buffer Elute using medium+ 10o/o serum 
(b) 
Figure 18 flow cytometry analysis after MACS separation using two different 
mobile phases. (a) unlabeled partition, (b) labeled partition 
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Figure 18 presents the flow cytometry analysis after MACS separation for 
both treatments. A remarkable decrease in the debris ratio in the annexin negative 
fraction was obtained under the treatment with the medium with lOo/o serum to 
elute the column, about 23- 70o/o reduced, depending on the initial cell status and 
loading amount. Comparing the result to the raw sample from middle growth phase, 
although medium with 10o/o serum as mobile phase could not prevent the 
occurrence of debris generation during passing the column, it significantly reduced 
the total number of the debris in the annexin negative fraction. It demonstrates that 
serum can act as a shear protecting agent in hard condition during cell separation. 
However, the labeled, annexin positive, fraction contained a considerable 
percentage of unlabeled cells using medium with lOo/o serum as mobile phase. It is 
possible that some components in serum, such as fibronectin, promote attachment 
of cells to the substrate. Separation theory for MACS system indicates that all non-
magnetically labeled cells should elute from column. In this case, target labeled cells 
as well as non-target cells could be clumped and a certain amount of the undesired 
cells were retained on the column. This made the very high unlabeled cell 
contamination in apoptotic fraction, resulting in a reduced purity. 
5.2.4. Comparison of MACS and other separation methods 
To further enrich for healthy or early apoptotic cells, other separation 
techniques, such as ATPSs and density gradient centrifugation were performed. 
Preliminary results under fluorescence microscope show that though the apoptotic 
cell population contains varying degrees of early and late apoptotic cells, it is 
82 
interesting to note that early and late apoptotic cells have some differences in 
morphology as well as viable and dead cells have physical differences like size, 
shape and density. 
5.2.4.1. ATPSs 
ATPSs have been used for the isolation and characterization of different 
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types of cells. This is a conventional technique that can separate cells easily and 
effectively without using antibodies. The studies completed by Nam et a/[88] 
determined a favorable condition to separate CHO cells. The optimum pH for the 
fractionation was 6.6, however the pH for our experiments is 7.4. The value of pH 
affects both surface charge and hydrophobicity[113]. Therefore, the surface 
properties of mammalian cells have a significant effect on fractionation efficiency 
using ATPSs. To test the fractionation efficiency of viable and dead CHO cells 
partitioned at pH 7.4, viable and dead cells were mixed at a ratio of viable to dead 
cells around 2:1 for test. After cell separation, viable cells were distributed to the 
PEG-rich top phase with a fractionation efficiency of 80-88%. With the increasing of 
settling time, the cells were distributed on the interface by sedimentation. A 
modified ATPS process using centrifugation during phase separation was 
investigated to accelerate the process and improve separation efficiency. However, 
although the viability was improved, when we checked apoptotic ratio, a significant 
population of apoptotic cells still existed before and after ATPS. 
Previous research on cell separation using MACS and ATPS respectively 
shows that there is a gap on loading capacity to combine MACS and ATPS due to the 
working concentration. MACS has a high loading capacity is around 2x1os cells/mi. 
However, one-step of ATPS is approximate 2x10s cells/ml, much lower than MACS. 
Generally, centrifugation can narrow the gap. However, the total initial cells number 
is -108 to make sure get enough enriched apoptotic cells. That means approximate 
SOOmL of ATPS working solution needed to satisfy the heavy work. In order to 
reduce the workload of ATPS, a high loading concentration was tested. In general, 
loading capacity and working volume are important factors to consider when 
evaluating cell separation processes. However, the test of high initial loading 
concentrations in one-step of ATPS has suggested that separation is not efficient. 
Concerns about its limited loading capacity have led us to develop and optimize a 
one-step of ATPS device. We propose to test multiple-step of ATPS instead of one-
step to increase the purity. Additional experiments will be developed to optimize 
separation, recovery and to maintain cell status. 
5.2.4.2. Ficoll gradient centrifugation 
Apoptosis is accompanied by water loss, cellular shrinkage and chromatin 
condensation in the early phase[30, 32, 54]. Viable CHO cells with density of 
1.051gjmL were reported[114] and the density ofapoptotic cells was found to be 
higher, 1.082-1.095gjmL[115]. We exploited these physical characteristics to 
develop our method to isolate apoptotic and non-apoptotic fraction, which is based 
on the evaluation of cell size, density, and surface details. Commercial product, 
Ficoll-Paque Plus containing 5.7% (w/v) ficoll400 (GE healthcare, NJ), and modified 
formula using Ficoll-400(Sigma, MO) and FBS were tested. Samples were taken 
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from the late exponential phase with an apoptotic ratio of 19.1 %. Centrifugation 
caused non-apoptotic cells to accumulate at the interface between the density 
gradient material and culture medium overlay and the apoptotic cells were enriched 
in the bottom phase. The results are presented in Table 7. 
Table 7 separation results of density gradient centrifugation under different 
treatment 
Material 
Density non-apoptosis Apoptosis 
(g/mL) Purity Recovery Purity Recovery 
Ficoll-Paque Plus 1.077±0.005 86.4% 48% 66.9% 19% 
10% Ficoll-400 1.049±0.010 83.6% 33% 51.8% 31% 
20% Ficoll-400 1.024±0.018 89.1 o/o 24% 34.2% 16% 
From the data above, the density gradient centrifugation process proved to 
be working with the healthy enrichment rates at around 4-fold and apoptotic 
enrichment rates at 2 to 3-fold. It performed lower efficiency than MACS, and more 
debris were generated due to the centrifugal force and interfacial tension. It then 
appears that apoptotic cell density and morphology were not high selectable 
markers. The recoveries were rather low due to samples taking form interface 
between layers. 
5.3. Discussion 
Our target is to realize fast isolation of apoptotic and non-apoptotic cell 
population with good purity and high throughout. Results derived from the 
application ofMACS to obtain two different subpopulations, healthy and apoptotic 
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cells, present encouraging results. While previous reports had focused on apoptotic 
depletion, such as immunomagnetic separation of membrane-intact and non-
apoptotic spermatozoa[109, 116], in our study we attempted to evaluate the 
performance of the modified separation technology to obtain the two selections 
together. 
It was shown that using the modified procedure we achieved higher 
separation efficiency compared to what we obtain from the standard procedure 
suggested by the vendor. This can be because the standard procedure is designed 
for depletion strategy (negative selection). The standard procedure uses the 
magnetic beads over its saturation value to ensure that the maximum binding 
equilibrium is reached. The supersaturation would reduce the purity of positive 
selection as we discussed previously. To increase the separation efficiency of 
positive selection, different amounts of binding beads were applied in different cell 
status, exponential growth and stationary phase, respectively. 
A debris-reduced fraction can be obtained by modifying the mobile phase. 
We attempted to evaluate the effect of growth medium with serum instead of 
normal binding buffer from the standard procedure. When the separation process 
during passing column was applied, the separation column could be viewed as an 
affinity chromatography, the binding interactions on apoptotic cells dependent on 
the strength of antibody-antigen interaction. 
Growth medium with serum would reduce the mechanical damage as well as 
the binding strength. Using this strategy, we could only obtain enriched viable cells 
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in non-apoptotic fraction at the expense of recovery for the samples from the 
stationary phase. However, for apoptotic fraction, to obtain higher purity, higher 
binding level was required, standard binding buffer was used as the mobile phase. 
From the brief comparison among MACS, ATPS and density gradient 
centrifugation, it is clear that MACS is the best method to obtain non-apoptotic and 
apoptotic fraction with high purity and throughout. Even with a modified ATPS 
process, we haven't achieved stable and high separation efficiency. Similar results 
were obtained with gradient centrifugation. This can be because both ATPSs and 
gradient centrifugation depend on cell's physical criteria, unlike MACS, which is 
based on affinity. Although other separation systems are not as good as MACS using 
annexin V, many morphological as well as biochemical. differences between 
apoptosis and non-apoptosis are observed. 
In conclusion, it has been experimentally demonstrated that it is possible to 
obtain high purity apoptotic (less than 10% of contamination by others) and healthy 
fractions (less than 3% of contamination by apoptotic cells), which provides 
samples for further analysis, such as metabolic flux and proteomic analysis. 
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Chapter 6 
Estimation of Specific Glucose Uptake 
Rates in Early-apoptotic State in 
Culture of CHO Cells 
6.1. Introduction 
Assimilation of glucose reflects the physiological state ofthe cell culture. The 
uptake rate of glucose will also help in determining the importance of metabolic 
regulation. Evaluation of glucose uptake ability in cells plays a fundamental role in 
glucose metabolism. Glucose is essential for the survival of cells, and the levels of 
glucose uptake are dynamic and regulated, which can be seen as cells display 
increased glucose uptake during growth and decrease glucose uptake when cells 
undergo apoptosis. The early apoptosis is regulated by the rate of glucose transport 
[106, 117-118]. But it has not been reported how much the glucose uptake rate 
decreases from healthy to early apoptotic state. The fluorescent glucose analog, 2-
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[N-(7-introbenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose (2-NBDG)[119] may 
provide an indicator for the rate of glucose uptake. It is rapidly uptaken by cells and 
hence accumulates in cells to a quasi steady state. 2-NBDG was reported to be 
transported intracellularly by mammalian cells via glucose transporters (GLUTs), 
the same as glucose [120-121], and also to be phosphorylated by hexokinase at C-6 
position as the final accumulation to give fluorescent 2-NBDG-6-phosphate. 
If the healthy and apoptotic population will be monitored in the same 
culture, one difficulty with the measurement and characterization of the glucose 
uptake for different populations is the fact that only the apparent uptake rate of 
total cells can be measured in the same pool using common methods. In this 
research, we developed and implemented a fluorometric method to directly 
evaluate glucose uptake rates of healthy and apoptotic cells combining a fluorescent 
glucose analog with an apoptosis dye, annexin V-PE, at the same condition without 
separating cells. In addition, since it is hard to measure the intracellular 2-NBDG 
concentration accurately, there has been no report previously to quantitatively 
characterize the glucose uptake rate by acquiring the fluorescent density. We 
applied Michaelis-menten Kinetics equation to obtain the quantitative relationship 
between measured mean fluorescence intensity (MFI) and intracellular 2-NBDG 
concentration (CA)· Our results clearly demonstrate that combination of2-NBDG 
and annexin V-PE can be used to accurately and reproducibly measure and 
distinguish glucose uptake rates between apoptotic and healthy cells .. 
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6.2. Theory 
Considering cells taking up glucose and 2-NBDG using a protein-mediated 
specific system, which can be described by Michaelis-Menten Kinetics as[122] 
(11) 
And 
(12) 
Where PT is the glucose transporter density on the cell membrane, Ac is the 
cell membrane area, kcat represents the constant rate, [G] and [A] are the 
extracellular concentration of glucose and analog, 2-NBDG, respectively, and KG and 
KA are the half saturation constant, respectively. 
Apply the competitive inhibition mechanism due to 2-NBDG is a the 
competitive inhibitior of glucose for uptake 
And 
r - p A k [A] A - T C catA KA(l+[G])+[A] 
Kc 
r - A k [G) G - PT C catG Kc(l+[AJ)+[G] 
KA 
Then, the relationship between rA and rG could be described as 
( 
[G] ) 
_ kcatG KG(l+.fPl-)+[G] 
rG- -- [A] rA 
kcatA [ l KA(l+ik-)+[A] 
(13) 
(14) 
(15) 
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Under a given condition, assuming that all the factors are constant, the 
glucose uptake rate is directly proportional to the 2-NBDG uptake rate. 
In addition, 2-NBDG uptake rate can be estimated from the steady state 
distributions ofintracellular 2-NBDG concentration. The degradation of2-NBDG-6-
phosphate to a nonfluorescent metabolite was assumed as a first-order 
process[120-121]. Then the accumulation of intracellular 2-NBDG (CA) can be 
described as 
(16) 
Where kd is the kinetic constant of degradation. 
Ingrating with the boundary condition (t=O, CA = 0), the expression becomes 
(17) 
At steady state, r A is directly proportional to the intracellular 2-NBDG 
concentration (CA). 
6.3. Results 
6.3.1. Effect of 2-NBDG incubation time on MFI 
To obtain the optimal incubation time to reach steady state, cells were 
treated with 2-NBDG (10, 20, and 40tJ.M) for 10, 20, 30, 40 and 60 minutes, then 
washed with PBS and fluorescent intensities were measured. The time course of 
uptake of 2-NBDG is shown in Figure 19. The dynamics of 2-NBDG uptakes were 
similar in different treatments. Uptake followed a hyperbolic pattern with a fast 
initial uptake in the first 10 to 20 minutes, followed by a slower uptake approaching 
steady states values at approximate 30 to 40 minutes. An incubation time of 40 
minutes was selected for the analysis. 
Time course of 2-NBDG uptake 
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Figure 19 Time course of 2-NBDG uptake by CHO cells at various treatments 
Uptake levels of 2-NBDG were fairly low and slow to reach steady state at 
low concentrations of extracellular 2-NBDG. In addition, at the given extracellular 
glucose concentration, the competitive inhibition uptake was observed in figure 19 
as 2-NBDG is mainly transported by facilitative diffusion via GLUTs, consistent with 
previously published papers[122, 124]. In order to obtained rapid and high levels of 
uptake, high incubation concentrations of 2-NBDG would be applied (20, 40, and 
8011M). 
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6.3.2. Fluorescent density (D) has a linear relationship with the 
intracellular concentration of 2-NBDG 
The observed 2-NDBG signal value (V) may be considered to result from the 
contributions of fluorescent density (D) accumulated in the single cell, background 
(B) and noise (N), contributions. That is 
VMFI = Dz-NBDG + B + N (18) 
As a general rule, negative unstained background is at minimally about 10 
times noise, thus the noise N is not dominated, which can be considered together 
with background B. The measured signal value V without any dye can be considered 
as the sum of N and B. Thus, the fluorescent density of 2-NBDG in cells can be 
expressed from the difference ofV-B-N and D ~V-B. To address the relationship 
between fluorescent density and intracellular concentration of 2-NBDG, the 
extracellular 2-NBDG concentration ([A]) was considered, since at steady state, rA is 
directly proportional to the intracellular 2-NBDG concentration (CA) and r A can be 
described by [A] via Michaelis-Menten kinetics. Assuming that extracellular 2-NBDG 
concentration ([A]) keeps constant for a short incubation time, the independent 
variables -[1 and the dependent variable ..!., by fitting the regression line in least-A] D 
squares approach. Various concentrations of2-NBDG (10, 20, 40, and 80 J.l.M) were 
tested and the results were plotted as~ versus [:] according to the Lineweaver-Burk 
equation 2. = KA .2.. + - 1- in figure 20. The results satisfied Michaelis-Menten 
rA rmax (A] rmax 
kinetics and revealed fluorescent density (D) is directly proportional to the 
intracellular 2-NBDG concentration (CA). 
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6.3.3. Development of an assay to measure glucose uptake rates of 
healthy and apoptotic cells simultaneously 
In the flow cytometer FACSCanto II, 2-NBDG and PE shares the same blue 
laser but can be distinguished via different filters. Therefore, the healthy and 
apoptotic cells can be determined by annexin V-PE staining and their glucose uptake 
rates can be estimated from the 2-NBDG fluorescent intensity. Cells were treated 
with 2-NBDG (20, 40, and 8011M) for 40 minutes and then were stained with 
Annexin V-PE. Under this treatment, the 2-NBDG fluorescent intensity in PE positive 
population represented the glucose uptake rate of healthy cells, whereas glucose 
uptake rate of apoptotic cells was obtained from the 2-NBDG fluorescent intensity in 
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PE negative fraction. Uptake ratio of healthy to apoptotic cells was obtained from 
the ratio of 2-NBDG fluorescent intensities. From the scatter plots, with the 
treatment of 2-NBDG and Annexin V-PE together, cells were separated into two 
populations (Figure 21): the major population with Annexin V-PE negative was 
healthy cells has higher fluorescent intensity of 2-NBDG, while the minor population 
with Annexin V-PE positive was apoptotic cells and has lower fluorescent intensity 
of 2-NBDG. This demonstrates that glucose uptake rate decreased significantly in 
the early apoptotic cells, to values lower than healthy cells. In addition, it was found 
that only healthy and early apoptotic cells (Annexin V-PE positive, and PI negative) 
took up 2-NBDG, while late apoptotic cells (Annexin V-PE positive, and PI positive) 
revealed to be 2-NBDG negative and the fluorescent intensity of 2-NBDG was as low 
as the background, consistent with the previous studies using 2-NBDG for the 
assessment of cell viability[125-126]. Thus, deducting the late apoptotic background 
from Annexin V-PE positive fraction, the 2-NBDG uptake rate can be calculated. 
Figure 21 FACS dot plots staining with 2-NBDG and Annexin V-PE 
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Specific glucose uptake rates were calculated and the experimental data in 
cell exponential growth phase were analyzed by nonlinear regression. 
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Figure 22 Time course of glucose uptake rates for healthy cells (A) and early 
apoptotic cells (B) 
Specific glucose uptake rate of healthy cells were much higher than early 
apoptotic cells in cell exponential growth phase, and it strongly depends on the 
medium condition. In contrast, the specific glucose uptake rate of early apoptotic 
cells exhibited a constant at 8.2x10-9 mM cell-1hr-1(Figure 22). The specific glucose 
uptake rate in healthy was approximate 10 to 20-fold higher than early apoptotic 
cells in cell exponential growth phase. And, this ratio was much higher in the early 
cell growth phase after 24 hours. This demonstrated that the growth of healthy cell 
was somehow substrate limited, while once cells turned to apoptosis, a certain 
amount of glucose was required to trigger and maintain the apoptotic process. In 
the previous papers, apoptosis occurs as the result of glucose depletione in batch 
culture [38, 118, 120, 126, 129], however, it was found that although healthy cells 
mainly grew and kept its viability, apoptosis was activated in a small fraction of 
cells, even in rich medium. At the end of the cell growth phase, glucose depletion 
occurred and intracellular 2-NBDG concentrations reflected 2-NBDG uptake 
behaviors directly. 
6.4. Discussion 
Glucose uptake and metabolism play a key role in apoptosis, with the 
established paradigm involving decreased glucose transport [106]. In this study, 2-
NBDG was used as a glucose metabolism indicator. Using the glucose analog 2-
NBDG, healthy and early apoptotic cells were found to take up glucose but late 
apoptotic cells did not The same observation has been reported in variety of cell 
types to determine cell viability as well as to compare glucose uptake rates [119, 
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125, 130]. Previous studies [124, 130]of 2-NBDG in cancer cell lines have shown 
rapid uptake with a peak uptake within 15 minutes of incubation. Our result in CHO 
cells show the similar uptake kinetics and reach maximum constat after around 30 
minutes. As shown in figure 20, a Lineweaver-Burk plot reveals the linear 
relationship between fluorescent intensity of 2-NBDG and its intracellular 
concentration. Therefore, we validated NBDG as an accurate indicator to measure 
glucose uptake. 
After evaluating 2-NBDG's validity as a quantitative measuring tool, we 
assessed the utility of 2-NBDG and annexin V-PE simultaneously to quantitavely 
compare the glucose uptake rates between healthy and early apoptotic cells. In 
conclusion, our study provides an evaluation of the potential of2-NBDG in apoptotic 
cells. Healthy and early apoptotic cells have different glucose uptake rates. Glucose 
uptake is a key step in cell metabolism to control the rate of glucose utilization. Our 
data indicated early apoptotic cells have rather low glucose utilization. This 
measurement supports the ability of 2-NBDG to highlight the understanding of 
metabolic activities between healthy and apoptotic cells. 
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Chapter 7 
MFA of CHO Cells Metabolism in the 
Apoptotic and Healthy Phase 
7 .1. Introduction 
Metabolic Flux Analysis (MFA) has been become an important tool in 
metabolic engineering as part of in depth physiological studies for optimizing 
bioprocess. Using a metabolic reaction network in combination with cellular 
measurements and mass balances to calculate flux profiles can be used to 
understand cell metabolism. These metabolic pathways containing pathways 
contain glycolysis, tricarboxylic acid (TCA) cycle, pentose phosphate pathway (PPP), 
oxidative phosphorylation, glutaminolysis, the metabolism of other amino acids and 
biosynthetic pathways determine the fate of any carbon and nitrogen sources in 
mammalian cells under different environmental or genetic background. However, 
their metabolism takes place not only in the cytosol but also in the mitochondrion. 
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On the other hand, cell growth requires a complex medium. Although the 
metabolism of mammalian cells is very complex, MFA has been applied frequently in 
mammalian cell cultures. The first application was to use MFA and linear 
optimization to analyze hybridoma metabolism[131-132]. Subsequently, MFA was 
used for medium optimization. The effects of medium, supplements and toxins were 
studied via metabolic balancing, such as dissolved oxygen concentration on the 
metabolism ofhybridoma cellline[133], the effect of replacing glutamine by 
glutamate on the metabolism ofCHO cells[134]. On the other hand, the phenomenon 
of multiple steady states in continuous cultures of mammalian cells[135] was also 
investigated via metabolic flux analysis techniques. 
The above are only few of many examples for the applications of metabolic 
balancing to determine intracellular fluxes of mammalian cells during cell growth. 
Quantification of intracellular fluxes can help to determine the extracellular control 
parameters for cell culture technology. However, biopharmaceutical production in 
CHO cells is often decoupled from cell growth [1.36]. The coupling of cell growth and 
product formation indicates that the evaluation of the metabolic fluxes in non-
growth phase, such as apoptotic phase, can help in understanding cellular 
metabolism throughout the course of a cell culture cycle. The metabolic behavior of 
CHO cells at the healthy and apoptotic stage will be different due to the cell fate. The 
metabolic networks for each stage are in accordance with the general metabolism of 
mammalian cells and the specific pattern of consumption or excretion of 
metabolites during the specific stage. Inspired from Agnes' work [13 7]and the 
model between apoptosis and cell growth, our research was aiming at connecting 
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cell fate and metabolic state to build a model that covers central carbon metabolism 
and amino acid biosynthesis. A great deal of data has been gathered for the various 
biochemical pathways that are involved in the control and execution of 
apoptosis[32, 43-44, 57, 59]. This shows that the network of pro- and anti-apoptotic 
signals is very complex. A simplified metabolic pathway was proposed to show 
proliferation-apoptosis transition in CHO cell culture via MFA to link cell 
proliferation and cell death with metabolic behavior. Based on our results from 
MFA, we would try to explain the basis of variation in apoptotic and non-apoptotic 
cultures. 
CHO cell metabolism consists of thousands of enzymatic reactions. MFA can 
be a useful tool to reduce these complexities and get a better understanding of 
mammalian cells[96]. In this chapter strategies and methodologies are developed 
for quantifying the metabolic fluxes in early apoptotic CHO cells. A simplified 
metabolic network is shown in figure 23. The individual flux reactions 
corresponding to the metabolic pathway are listed in the appendix. Two 
compartments, cytosol and mitochondrion, are considered to represent the 
presence of the same metabolite in distinct pools as well as mitochondrion/cytosol 
transfer reactions. The biomass composition ofCHO cells is taken from Altamirano 
result[134], which are similar to typical values found in the literature. The model 
consists of glycolysis, the pentose phosphate pathway (PPP), anaplerotic reactions, 
the tricarboxylic acid (TCA) cycle, amino acid metabolism, energy metabolism, and 
biomass formation. Some linear reaction sequences have been lumped to reduce the 
number ofbalance equations. The metabolism of amino acid is lumped into one 
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reaction until reaching a metabolite in the central carbon metabolism, which is 
derived from [138] and curated using primary literature. 
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Figure 23 MFA Model A) Glucose metabolism and B) Amino acid metabolism 
7.2. Results 
7.2.1. Metabolic investigations on CHO cells between healthy and early 
apoptotic cells 
Preliminary study showed that in the process of mammalian cell culture, 
apoptotic rate increases once glucose is exhausted. However, other nutrients like 
amino acids are not depleted, which shows that during the initiation of apoptosis in 
cell culture, depletion of glucose is dominant. The result from combination of 2-
NBDG and Annexin V-PE showed significant differences on glucose uptake rates for 
healthy and early apoptotic cells. The specific glucose uptake rate of healthy cells 
were found to follow Monod model, while the specific glucose uptake rate of early 
apoptotic cells did not follow the Monod model and instead exhibited a constant. 
The specific glucose uptake rate in healthy was approximate 10-fold higher than 
early apoptotic cells. The low activity of the glucose uptake of early apoptotic cells 
indicated that a possible steady state assumption for the extracellular condition 
could be applied for the metabolic flux analysis in early apoptotic cells. During the 
late exponential phase, most of the cells are from healthy to early apoptotic status 
and the metabolism of amino acids and glucose is assumed to serve this process. A 
metabolic steady state for early apoptotic cells is assumed that no matter what kind 
of phases cells are, exponential or stationary, the metabolic behaviors of early 
apoptotic are similar. Thus, the measurements of the consumption of amino acids 
and glucose, and the generation oflactate from the late exponential phase can be 
considered as the metabolic behavior of the early apoptotic cells and work for all 
cell phases throughout the course of a cell culture cycle. 
The profiles of the consumption of glucose and the generation oflactate are 
presented in figure 24. Once glucose was depleted, cells entered death phase. Also at 
the same time, the level oflactate reached the maximum level. Although these data 
were simple, they showed the relationship between cell death and the 
environmental factors. In any case, when cells are grown at a high specific growth 
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rate (figure 11 ), sooner or later some limiting conditions would be reached and the 
culture would start the irreversible death phase. At physiological levels of glucose, 
most of them is converted to lactate and the higher the glucose level in the medium, 
the higher the rate of this conversion. On the other hand, under low glucose 
concentration, the glucose is preferentially used for biosynthesis[SS]. When glucose 
was depleted, the lactate produced by the consumption of glucose in CHO cells 
seems to be converted back to pyruvate and then be channeled towards TCA cycle. 
Similar finding were reported by Altamirano et al[139], and Tsao et al[140] at low 
glucose concentrations. And Tsao also hypothesized that glucose and lactate were 
both considered as carbon sources. However, when the concentration of lactate 
decreased, cells were almost in late apoptotic stage, where they lose the ability of 
uptake nutrients, and nutrients could not be used. It should be noted that this 
unique behavior might be related to the cell line and culture conditions. 
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Figure 24 Profiles of glucose consumption and lactate formation 
The metabolite concentrations were plotted against the corresponding 
glucose concentrations. Rates were determined from the plots using linear 
regression at two distinct growth phases, at exponential growth phase and at 
stationary phase. In the case of amino acids, most of them followed a linear 
relationship to glucose consumption during the exponential growth phase. 
However, few of them did not show linear relationship to glucose consumption very 
well, such as lysine, asparagines, and methionine. In the healthy cells, among the 
amino acids, aspartate, alanine and glycine showed production while all the others 
were consumed. On the other hand, in the apoptotic cells, only alanine was 
generated while all the others were consumed. During the exponential phase, the 
specific rates of metabolites formation were calculated using the equation [133] 
[S] = [So] + qsXo (e~t- 1) 
11 
where q5 is the specific rate, [S]is the measured metabolite concentration, 
[S0] is the initial metabolite concentration, [S0] is the initial biomass, fl. is the 
specific cell growth rate and tis the time. While the specific rates of metabolites in 
early apoptotic were estimated using the measured metabolite concentrations at 
stationary phase with the equation 
qsX [S] = [S0] + --t- t 0 
where t 0 is the initial time point 
The data are shown in Table 8 for the cases studied for MFA. 
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Table 8 Calculated specific uptake rates in healthy and early apoptotic cells 
Metabolite Qsin healthy cells 
Qs in early 
Unit 
apoptotic cells 
Glucose -0.15 -0.0082 mmol106 celJ-lh-1 
lactate 0.20 0.0012 mmol106 celJ-lh-1 
ASP 0.43 -0.21 IJ.mol106 cell-1h-1 
THR -2.90 -0.14 1J.mol106 celJ-lh-1 
SER -11.22 -0.29 1J.mol106 celJ-lh-1 
ASN -14.79 -0.79 IJ.ffiOl106 celJ-lh-1 
GLU -9.38 -2.49 IJ.mol106 celJ-lh-1 
GLY 11.46 -0.27 IJ.mol106 celJ-lh-1 
ALA 4.30 0.36 1J.mol106 celJ-lh-1 
VAL -3.02 -0.19 1J.mol106 celJ-lh-1 
CYS -11.51 -0.26 1J.mol106 cell-1h-1 
MET -7.26 -0.09 IJ.mol106 celJ-lh-1 
ILE -4.85 -0.22 1J.mol106 celJ-lh-1 
LEU -3.34 -0.09 1J.mol106 celJ-lh-1 
TYR -2.91 -0.31 1J.mol106 celJ-lh-1 
PHE -3.44 -0.16 1J.mol106 celJ-lh-1 
LYS -2.95 -0.32 1J.mol106 celJ-lh-1 
HIS -1.13 -0.08 IJ.mol106 cell-1 h-1 
ARG -3.88 -0.49 IJ.mol106 celJ-lh-1 
PRO -3.83 -0.04 1J.mol106 celJ-lh-1 
This basic study will help us understand the intracellular behavior of glucose 
and other metabolite concentrations on the whole cell culture span and the 
relationship between the level of glucose and apoptosis, and additional experiments 
are required to design for supporting this initial evidence. 
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7.2.2 Estimation of intracellular fluxes 
MFA was conducted to obtain the intracellular fluxes using the extracellular 
measurements. The reaction network model for CHO cells is presented in Appendix 
A. This model was applied for estimation of intracellular fluxes using external 
measurements. The fluxes evaluated by stoichiometric modeling are listed in Table 
9. 
Table 9 Calculated intracellular fluxes via c-MFA 
Healthy Early apoptotic 
Glycolysis 
24 GLC+ATP-+ADP+G6P 150.01 8.2 
25 G6P +-+F6P 146.95 8.2 
26 F6P + ATP +-+ 2GAP+ADP 147.31 8.2 
27 ADP+GAP+NAD+-+ATP+H20 +NADH+PEP 293.52 16.4 
28 ADP+PEP-+ATP+PYR 293.52 16.4 
29 NADH+PYR +-+LAC+NAD 200.00 2.2 
Pentose Phosphate pathway 
30 G6P + 2NADP+ -+ 2NADPH + C02 + R5P 1.096 0 
31 2R5P -+ GAP + S7P 0 0 
32 GAP + S7P -+ E4P + F6P 0 0 
33 X5P + E4P ....... F6P + GAP 0 0 
Mitochndrial Transport 
34 PYR +-+PYR(m) 120.04 14.74 
35 MAL+-+MAL(m) 101.19 16.29 
36 AKG+-+AKG(m) -128.59 -18.39 
37 MAL +CIT(m) +-+MAL(m)+CIT -1.61 -0.94 
38 ASP(m)+GLU +-+ASP+GLU(m) -94.86 -15.30 
39 GLU(c) -+GLU(m) 45.17 6.19 
Anaplerotic reactions 
40 PYR(m)+NAD(m) -+AcCoA(m) +C02+NADH(m) 151.03 19.33 
41 MAL +NADP-+C02+NADPH+PYR 11.40 0.48 
42 MAL(m)+NADP(m) -+C02+NADPH(m)+PYR(m) 281.91 -6.19 
43 OAA+ATP-+PEP+ADP+C02 0 0 
44 PYR(m)+C02+ATP(m)+-+0AA(m)+ADP(m) 252.02 -10.78 
TCAcycle 
45 AcCoA (m)+ OAA(m)-+CIT(m) 157.16 20.46 
46 CIT(m)+NAD(m) -+AKG(m)+ C02+NADH(m) 158.77 21.40 
47 AKG(m)+NAD(m) -+SUCCoA(m)+C02+NADH(m) 170.20 24.50 
48 GDP(m)+SUCCoA(m)+FAD(m)-+FUM(m)+FADH2( 181.45 25.00 
m)+GTP(m) 
109 
49 FUM(m)+H20+-+MAL(m) 182.33 25.00 
50 MAL(m)+NAD(m) ->OAA(m)+NADH(m) 184.05 46.53 
51 MAL +NAD ->OAA+NADH -103.66 -15.36 
Amino acid metabolism 
52 ARG+AKG+NAD +-+2GLU(c)+NADH(c)+C02+ 2.01 0.49 NH4+ 
53 ASN+-+ASP+NH4+ 13.63 0.79 
54 ASP+AKG +-+OAA+GLU 105.27 16.30 
55 ASP(m)+AKG(m) +-+OAA(m)+GLU(m) -94.86 -15.30 
56 CYS+AKG->PYR+GLU+ NH4+ 17.35 0.35 
57 GLN<->GLU+ NH4+ -3.37 0.00 
58 GLU(m)+NADP+(m) ->AKG(m)+NADPH(m)+ 45.17 6.19 NH4+ 
59 GLU+PYR +-+AKG+ALA 7.11 0.36 
60 2GLY+NAD+->SER+NADH+C02+ NH4+ 4.30 -0.14 
61 HIS+NAD+->GLU+C02+NH4++NADH 0.49 0.08 
ILE+AKG+ATP(m)+NAD+(m)+FAD+(m)->GLU+Ac 
62 CoA(m)+NADH(m)+FADH(m)+SUCCoA(m)+ADP( 3.31 0.22 
m) 
63 LEU+AKG+ATP(m)+FAD+(C)->GLU+3AcCoA(m)+F 0.73 0.09 ADH2(m)+ADP(m) 
LYS+AKGNADPH+2NAD++2NAD+(m)+FAD(m)--+2 
64 GLU+2C02+2AcCoA(m)+2NADH(m)+2NADH+FA 0.31 0.36 
DH2(m)+NADP+(m) 
65 MET +SER+3ATP+ATP(m)+NAD+(m)->CYS+SUC 6.67 0.09 CoA(m)+C02+NH4++3ADP+ADP(m)+NADH(m) 
66 PHE+NADPH--+ TYR+NADP+ 2.81 0.16 
67 PR0+2NAD++-+GLU+2NADH 3.00 0.04 
68 SER--+NH4+ +PYR 7.07 0.07 
69 THR+NAD(m)+FAD(m)+NAD->PYR(m)+FADH2(m) 1.09 0 
+NH4++NADH(m)+C02 
TRP+2NAD+(m)+FAD+(m)+NADPH->ALA+4C02+ 
70 2AcCoA(m)+ 0 0 
NH4++2NADH(m)+FADH2(m)+NADP+ 
71 TYR+AKG->MAL +C02+2AcCoA+GLU 5.14 0.47 
VAL+AKG+ 
72 2NAD+(m)+FAD+(m)--+SUCCoA(m)+GLU+ 1.27 0.19 
2NADH(m)+FADH2(m) +C02 
Both the TCA cycle and glycolysis provide most of the redox equivalents for 
cellular respiration. It is clearly shown that there is efficient utilization of glucose 
and amino acids from the results obtained via MFA by healthy and early apoptotic 
cells. As far as glucose, the limitation of glucose will decouple some modules in 
metabolic network, such as glycolysis and TCA cycle, leading to abnormal metabolic 
states. The glycolysis limitation will potentially trigger apoptosis[141]. Pyruvate is a 
key intermediate between glycolysis and TCA cycle. Pyruvate is a key metabolite in 
central metabolism since it is the end product of glycolysis, and most of the 
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fermentative products are derived from it. Pyruvate is also an important precursor 
metabolite for the biosynthetic building blocks. Therefore, it is important to analyze 
metabolic flux distribution around pyruvate. The pyruvate ratio (PR) is used to 
indicate the efficiency of pyruvate channeling to TCA cycle for energy generation. 
PR was calculated using the equation 
where the numerator represents the flux of pyruvate entering mitochondria 
for TCA cycle, while the denominator represents the fluxes of pyruvate generation. 
Thus the limit of PR is 1 and values close to 1 indicate high energy efficiency from 
glucose. The calculated values are presented in table 9. The significantly high value 
of PR in early apoptotic cells indicated that most of the flux from pyruvate was 
diverted towards the TCA cycle, whereas, in healthy cells under growth conditions, 
most of the pyruvate was channeled to lactate. Similar trends in pyruvate has been 
observed by Sengupta et al[142] in the study of metabolic flux analysis of CHO cells 
in the non-growth phase. 
In the metabolism of mammalian cells, glutamate and a-ketoglutarate are 
also key metabolites and prominent intermediates. Once glutamate is transported 
into the cell, its fate is determined by glutamate dehydrogenase (GDH) or 
transaminases. GDH deaminates glutamate to a-ketoglutarate and channels it 
towards the TCA cycle. On the other hand, glutamate can be converted to a-
ketoglutarate via the activities of glutamate dehydrogenase (GDH), alanine 
transaminase (AlaAT) or aspartate transaminase (AspAT). In the case of oxidation 
~ ~·----------------
111 
by GDH, glutamate can be oxidized completely to COz via TCA cycle and yield 27 
molecules of ATP, whereas, in the transamination pathways by AlaA T or AspAT, 
only 6 to 9 molecules of ATP will be generated[134, 143]. Therefore, when more 
energy is required, glutamate is deviated towards the efficient oxidation pathway. 
Thus, the glutamate oxidation ratio (GOR) is used to indicate the efficiency of 
utilization of the main nitrogen source, glutamate, for energy generation. GOR was 
calculated using the equation 
GOR = Vsa 
Vsa + Vs4 + Vss + Vs9 
where the numerator represents the flux of glutamate oxidized to a.-
ketoglutarate, while the denominator represents the fluxes of all the fate of 
glutamate in central metabolism by GDH and transaminases. Thus the limit of GORis 
1 and values close to 1 indicate high energy efficiency from glutamate. The value of 
GORin early apoptotic cells is higher in the healthy cells (Table 10), indicating that 
glutamate plays a major role in maintaining a high activity of TCA cycle during 
glucose limitation causing by low glucose uptake rate in early apoptotic cells. This 
result is similar to the metabolic shift observed in other cell lines at low glucose 
concentrations[23, 129, 134]. 
Taken together, the analysis of flux distribution around the TCA cycle 
indicated that in early apoptotic cells, the flux of pyruvate to TCA cycle was very 
high with very low or no lactic acid production, and TCA cycle was also 
compensated by higher incorporation of glutamate oxidation to recover the ATP 
level serving the apoptotic process. 
Table 10 distribution of metabolic fluxes around pyruvate and glutamate-- a-
ketoglutarate 
parameter 
PR 
GOR 
Healthy 
0.36 
0.72 
Early apoptotic 
0.85 
0.81 
In the case of amino acids, although most of the cell culture media contain all 
the twenty amino acids, only five of them, aspartate, glutamate, serine, glycine and 
alanine, are consumed for energy production[98] and, interestingly, only these five 
amino acids were reported to be biosynthetically labeled by [U-13C] glucose[144]. 
These five amino acids were compared together and showed significant difference 
between healthy and early apoptotic cells. A comparison of the normalized rates to 
uptake rate of glutamate (Table 11) reveals that the glutamate is the major amino 
acid consumed during early apoptotic stage. The negative values of fluxes of glysine 
and aspartate in healthy cells indicated that higher fluxes of transamination reaction 
in the metabolism of glutamate. These results agree with the conclusion derived 
from GOR values. Results from the fluxes of amino acid metabolism indicated that 
the contribution of other amino acids to TCA cycle intermediates was almost 
negligible in early apoptotic cells and they only contributed to the synthesis of some 
key enzymes involved in apoptotic process. Comparison to glutamate, the 
consumption rates of other amino acids were close to negligible. The dramatic high 
value of glutamate uptake also reveals that glutamate plays a key role in energy 
metabolism instead of glucose in the early apoptotic cells. However, in healthy cells, 
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the uptake rates of each amino acid were comparable, indicating that they are 
mostly utilized for biomass synthesis, including glutamate. 
Table 11 extracellular fluxes (normalized to glutamate uptake, mol/mol 
glutamate) 
Healthy Early apoptotic 
GLU 1 1 
SER 1.20 0.11 
ALA 0.46 0.14 
GLY -1.22 0.18 
ASP -0.05 0.08 
7 .3. Discussion 
Metabolic flux analysis shows the significant metabolic differences between 
healthy and early apoptotic cells. Our results indicate that early apoptotic state is 
not necessarily associated with a shutdown of metabolism. Early apoptotic cells are 
actually metabolically very active. A higher efficiency of glucose and glutamate 
utilization was observed during the apoptotic process. The general flux trends, 
normalized respect to glucose uptake, are compared in figure 25, which shows the 
decoupling of glycolysis and TCA cycle and the decoupling between glucose and 
glutamate utilization. This metabolic shift from healthy to early apoptotic cells with 
the high efficiency of major nutrient utilization indicates that apoptosis requires 
energy to fulfill the process. 
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Figure 25 Comparison of flux trends in (A) healthy cells (B) early apoptotic 
cells 
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The c-MFA method utilizes a balance on stoichiometric matrix in order to 
resolve the intracellular fluxes. One of the first problems encountered in this 
approach is that the system is underdetermined. The pentose phosphate pathway 
(PPP) is an underdetermined network together with glycolysis and TCA cycle[95]. 
The PPP contains oxidative reactions with the generation ofNADPH and non-
oxidative reactions via transaldolase and transketolase. Both the oxidative and non-
oxidative parts are considered in the proposed model (Figure 23). However, when 
the measured extracellular fluxes were applied on the stoichiometric matrix to 
calculated the fluxes of PPP, both results in healthy and early apoptotic had the 
exactly zero flux in oxidative branch and ribose-5-phosphate was formed through 
the transaldolases and transsketolases. And there was no significant difference 
between healthy and early apoptotic cells. Without more information, the PPP was 
lumped into one reaction just for both the generation ofNADPH and the generation 
ofribose-5-phosphate for nucleotide synthesis in our c-MFA. However, the PPP 
operate in different modes depending on the cellular status and requirement, and 
there should be a balance between oxidative and non-oxidative branches. Figure 25 
has shown the dicoupling of glycolysis, TCA cycle, and amino acids metabolism in 
early apoptotic cells. It should be similar to the PPP for the different demand for 
NADPH and PPP intermediates. The fluxes in PPP for healthy and early apoptotic 
cells need to be considered carefully due to the following observations: 
1) For rapid growing healthy cells, oxidative branch is inhibited by high fructose-
1,6-biphosphate[l45-146], and non-oxidative branch is active. 
2) Expression of apoptotic gene p53 leads to inhibit the non-oxidative and redirect 
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glucose to oxidative branch[147]. 
For the accurate quantification of the fluxes in PPP, it is necessary to 
compliment the stoichiometric balancing of metabolites with isotopic labeling 
analysis. The rate of oxidative branch of PPP can be estimated via [1,2-13(2] 
glucose[126, 145, 148]. 13C2lactate is directly derived from glycosis whereas 13(1 
lactate originates from glucose metabolized by oxidative PPP and then recycled to 
glycolysis by non-oxidative branch. This shows that labeling flux analysis is largely 
free from the drawbacks discussed for the c-MFA. It employs a balance on labeled 
carbon bonds, and since each isotopic isomer of a compound can be regarded as a 
separate metabolite, there are huge numbers of measurements available to get an 
estimate of fluxes with high degree of confidence. 
In conclusion, in early apoptotic cells, metabolic profiling shows specific flux 
shifts in glycolysis and TCA cycle, and reveals major changes in glucose and 
glutamate utilization. A more comprehensive analysis using advanced techniques, 
such as labeling MFA, could bring more information in metabolic pathways like 
pentose phosphate pathway, aspartate-malate shuttle, fatty acid synthesis and so on 
to compare the metabolic shift in early apoptotic cells. Metabolic flux analysis 
provides vital information beyond the genetic and signaling pathways studies on 
apoptosis, indicating that a metabolic shift in carbon flow and amino acid 
metabolism is taking place in the transition from healthy to early apoptotic cells. 
Therefore, metabolic flux analysis is a powerful tool to identify crucial targets and 
can help elucidate the complex mechanisms mediating apoptosis in cultured 
mammalian cells. 
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Chapter 8 
Conclusions and Future Work 
The overall project aim of this work was to achieve an improved 
understanding of apoptotic behavior in cultured CHO cells. CHO cells are a powerful 
model system for studying mammalian cell culture. A major problem faced in 
culture is cell death. Apoptosis is a genetically controlled process but it is still 
recognized as an unclean in cell culture. The better understanding of metabolic 
behavior during the apoptosis, the better strategies will be devised to control the 
cell death during cell culture. 
Fluorescence imaging of annexin V-FITC and PI staining taken for batch 
experiments indicated that death of the CHO cells is primarily via apoptosis. This 
observation is similar to the previous reports [17, 32, 55, 59, 149]. The 
condensation of chromatin and shape changes were both observed in bright field 
and fluorescent field. Fluorescence imaging captured the changes in cellular 
morphology along the course of cell culture. At the same time, to further confirm 
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this observation and quantitatively investigate the transition behavior, another kind 
of immunofluorescent technique, FACS, was applied to detect and monitor the 
transition of apoptotic cells and estimate subpopulations. The healthy, early 
apoptotic and late apoptotic cells were distinguished and samples collected under 
different culture time and conditions used to establish the link between metabolism 
and apoptosis using metabolic flux analysis. Significant morphology changes and 
dramatic high apoptotic rate were found at the end of the exponential growth phase, 
coinciding with the exhaustion of glucose, providing the evidence that glucose 
metabolism and apoptosis are coordinated and indicating the importance of MFA to 
better understand apoptotic processes in cultured CHO cells. 
Considering the similarity between immunofluorescent technique and 
immunomaganetic technique, we used the results from F ACS and fluorescence 
imaging to optimize the Magnetic Activated Cell Sorting (MACS) process to separate 
different samples on the order of 107 cells to detect proteins expressed and labeling 
carbon mapping in future work. In our study, one of the early features of apoptosis, 
which is the externalization of phosphatidylserine (PS) residues normally present 
on the inner leaflet of the plasma membrane, was used. Colloidal paramagnetic 
microbeads conjugated with annexin V binding to PS was applied to separate 
healthy and apoptotic cells by MACS. Apoptotic cells with externalized PS can bind 
to these microbeads while healthy cells cannot and hence the subpopulation are 
separated by magnetic field. MiniMACS column was considered as an affinity column 
and the amount of antibodies and the mobile phase were optimized to get rather 
good purity in both negative and positive selections. The results of MACS to 
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partition apoptotic and non-apoptotic cells have shown that the modified procedure 
also had a high throughput and the loading capacity is around 2 xtos cells/mi. The 
advantages of the MACS method are 
1) simple and short procedure that does not require complex and specialized 
equipments. 
2) mild method during the fractionation, though some debris could be generated 
through the column. 
3) suitable for obtaining large amount of purified apoptotic and healthy cells and 
therefore could be easily introduced in other biochemical studies, such as proteomics 
and isotopomer labeling MFA. 
Most biochemical studies of apoptotic cells have been done on the whole cell 
populations treated with apoptotic inducers or inhibitors, and the results would be 
for the mixture of cells which are at various cellular stages. Using MACS has allowed 
us to examine the direct relationship between cells that are undergoing apoptosis 
and the metabolism or expression of apoptotic proteins. 
The results of fluorescence imaging and apoptotic kinetics showed a 
significant apoptotic change on glucose depletion. It is well documented that the 
activity of BAD, a pro-apoptotic Bcl-2 family member also serves as the regulator of 
glucokinase activity to ensure that glucose metabolism and apoptosis are 
coordinated[! SO], which is the first evidence for an association between cellular 
metabolism and the apoptotic process. On the other hand, the most studies on 
metabolism and apoptosis are the effect of Bcl-2 family members, which are key 
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regulators of the apoptotic pathway. It has been reported that loss of glucose leads 
to a decreased level ofanti-apoptosis proteins from Bcl-2 family[151]. In our 
research by combination of 2-NBDG and Annexin V-PE, the initial difference in 
glucose metabolism between healthy and early apoptotic cells is glucose uptake and 
this difference shows that early apoptotic cells have rather low uptake rate and the 
constant rate indicate that environment has low or no effect on early apoptotic cells. 
After glucose uptake, the difference between healthy and early apoptotic 
cells identified via metabolic flux analysis is a promising strategy, which can 
effectively link apoptosis and the metabolic shift. Under high density conditions in 
bioreactors, the mechanism behind the metabolic regulation of apoptosis in 
mammalian cells is still like a grey box because the whole process of apoptosis is too 
complex and many causes can trigger apoptosis in cell culture. Most recent 
experiments have focused on the inhibition of apoptosis by the over-expression of 
Bcl-2 family members. The major problem in the elucidation of apoptosis 
mechanisms in all cell culture system is the fact that there is no single parameter 
responsible for its initiation, nor a specific assay distinguishing between the 
apoptotic modalities. However, essential cellular and metabolic events are 
demonstrating the key processes throughout the whole life of cells. The use of 
metabolic flux analysis as model for apoptosis research to investigate the functions 
and interactions may be a powerful tool. We assumed late apoptotic cells did not 
have much of metabolic activity. The metabolism is activated in the early apoptotic 
stage, controlled by the active degraded proteases[16, 44, 47]. Flux maps of cultured 
CHO cells between apoptotic and healthy phase of batch culture were generated 
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using stoichiometric modeling. MFA indicated that most of flux from pyruvate was 
channeled towards the TCA cycle, only with little lactate production. Moreover, the 
utilization of glutamate was significantly high. In early apoptotic cells, the glucose 
uptake rate becomes lower than in healthy cells. We monitored the rate of 
glutamate consumption. The increase in glutamate uptake rate and oxidative rate 
has demonstrated that the glutamate is a necessary energy and carbon source for 
early apoptotic cells. Glutamate is the preferred anaplerotic source for carbon 
skeletons and energy generation. These results are in agreement with literature. 
Zwingmann et al[152] studied glucose metabolism in hepatocellular apoptosis and 
proposed a metabolic model for the whole process of apoptosis. They suggested that 
metabolic events of increased mitochondrial glucose oxidation and de novo 
synthesis of glutathione occur in very early apoptotic stages and they are possibly to 
mantain adequate energy levels in order for apoptosis to proceed. 
In addition, isoto mer labeling MFA, enzyme activity tests and proteomic 
approaches are performed to further explain the metabolic network and apoptotic 
process. The c-MFA analysis is based on the assumed metabolic network with all the 
assumptions from the reported findings. This conventional technique will not only 
validate the existing pathways for the apoptotic and healthy CH 0 cells, but will also 
help determine conditions and approaches required for the implementation of 
system-wide techniques. Labeling based experiments are powerful techniques to 
investigate metabolism. They not only have the capability to estimate intracellular 
fluxes to a high degree of resolution, but also provide information for refining the 
reaction network under consideration. Labeling based experiments provides us 
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with the capability to assess which reactions are active and which reactions are 
inactive between apoptotic and healthy cells. An important part of the future work 
will examine metabolism and estimate the flux in different cell phases. For this, we 
would use labeled 13C glucose or 13C glutamic acid for cell culture and analyze the 
labeling pattern of metabolites in different metabolic pathway using NMR 
spectroscopy. The labeling pattern we obtain can bring more information to 
investigate into the metabolism of apoptotic and non-apoptotic cells. 
For the analysis of 13C-based metabolic flux, most of them use GC/MS, 
because MS is significantly more sensitive than NMR[153]. Miccheli et al [154]. That 
is the reason why most of the lab which focused on 13C labeling MFA used GC/MS to 
measure labeled metabolites. Recently, the sensitivity of NMR analysis has 
significantly improved. [155], but the sample amount is rather high. For 1H-NMR, 
3 X 107 cells per sample are collected, while for 1-D 13C-NMR or 2-D [13C, lH] 
HSQC, 1.8-3 X 108 cells per sample are required [56, 89, 156-157]. When 
proliferating mammalian cells are at metabolic steady state, labeled glucose can 
achieve isotopic steady state within glycolysis, the pentose phosphate pathway and 
the TCA cycle within 6 hours of application [56, 89, 156-15 7]. Among those tracers, 
[U-13C6]glucose and [1,2-13C2]glucose are commonly used in mammalian cells. 
The methodology for estimation of fluxes using labeling pattern of amino 
acids is discussed in section 2.4. The reaction network model and carbon 
rearrangement model are constructed for the purpose of intracellular flux 
estimation, further for the difference between apoptotic and non-apoptotic phases 
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according to the intracellular flux estimations. In our reaction network model, we 
have lumped most of amino acids metabolism. All of these amino acids can be 
connected by TCA cycle (figure 3). So, the amounts of these amino acids must be 
appropriately balanced. Amino acids must be supplied form the media to ensure the 
metabolic functions of mammalian cells and supply the required amounts in a 
balanced state. The absence of any of these amino acids would trigger the onset of 
cell death.[7, 11, 17]. So we will consider the data obtained from the culture of cell 
with [U-13C] glucose and [U-13C] glutamic acid. The final carbon fractional labeling 
in amino acids would give more information into the changes in amino acid 
utilization during apoptosis. 
On the other hand, system-level analysis can be used to enhance the 
understanding of complex biological processes. With the estimated parameters, it 
becomes possible to reproduce the observed system behavior and to predict 
important system properties of apoptosis in mammalian cell culture. Based on 
classical analysis of the correlation of apoptosis and culture conditions, metabolic 
characterization and proteomics are powerful approaches for global study. We 
would try to analyze the difference in biological data between apoptotic and non-
apoptotic cells and unravel the functions and interactions during CHO cell culture. 
Depending on the results from the conventional analysis, the conditions of system-
level comparison will be identified. Then according to the comparison, the study of 
system-wide responses to different stages of cell behavior should consider the 
identification of proteins and reactions or pathways involved in cell apoptosis. 
Although the metabolic and apoptosis pathways are distinctly different, they 
123 
converge on a shared set of proteins. Proteomics is then a promising approach to 
investigate biochemical processes on the protein level. Therefore, the investigation 
ofthe phenomenon ofapoptosis will use proteome research in our study. Much of 
the evidence for the link between environmental stimuli, cellular metabolism and 
anti-apoptosis comes from the study of cancer cells[141]. This work will be 
designed in accordance with the culture condition and proteomics results, which in 
turn will help us find the pathways of apoptosis in CHO cell cultures. In this study, 
we will use the proteomic approach for the identification of proteins that are 
regulated according to the degree of apoptotic behaviors. Proteomics is the study of 
the expressed protein complement of a genome at a specific time and as a study of 
proteins expressed in a cell. Proteomics will facilitate the systematic analysis of 
protein molecules related to such a complicated biological system. Protein 
expression profiles including information about protein signatures, localization and 
their quantitative changes with extracellular stimulations are extremely useful to 
construct intracellular pathway models resulting in the apoptotic cell death. 
Hence the samples chosen by the preliminary work in different culture stages 
will be investigated with 2-D gel electrophoresis. In the two different collections, 2-
D gel electrophoresis-mass spectrometry approach will be applied to cellular 
protein samples for the identification of apoptosis associated proteins. As the 
samples are collected from the same culture condition, the effects from a vast 
number of extracellular factors are minimized, but the intracellular behaviors 
leading to the anti- or pro-apoptotic protein expression patterns in different cell 
stage need to be investigated. It is interesting to notice that although many new 
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apoptosis actors were identified, there are many of the proteins involved in 
apoptosis were not detected. Thus, the observations of samples collected from the 
same condition would overcome this limitation, and our proteomics approach could 
realize the real globe analysis. The behaviors of viable and apoptotic cells are 
rapidly bringing either up-regulation or down-regulation of proteins in both the 
central energy metabolic and apoptotic pathways. Some gel replicates can be carried 
out for apoptotic and non-apoptotic states, respectively, which will used for 
differential analysis. In this study, comparison of the protein profiling between 
different conditions can lead to ascribing genes related to cell apoptosis or growth. 
Furthermore, the functional analysis of proteins modified during apoptosis would 
be an important work. As soon as some proteins are identified and validated in the 
proteome mapping, the underlying molecular mechanism and the correlation 
between cellular growth and apoptosis become more straightforward. 
Overall, the results from functional genomics approaches will greatly 
improve the fundamental knowledge of apoptosis in mammalian cell culture. 
Apoptotic stimuli are inherent in the high cell density at the late cell growth 
exponential phase due to the nutrient depletion in our CHO cell in batch culture. 
Such evidence suggests the hypothesis that the effects of environmental factors that 
switch CHO cells from healthy status to apoptotic status are reflected by metabolic 
phenotype changes. Depletion of the energy supply will decouple the link between 
each module in metabolic network, such as glycolysis, the pentose phosphate 
pathway and the TCA cycle. The unbalance of metabolic will limit the function of 
some enzymes and trigger apoptosis. The changes of metabolism can be detected to 
125 
analyze their effect on apoptosis programs, especially glucose metabolism can be 
monitored to provide information on metabolic changes in response to cell stresses. 
So in order to bring novel strategies to understand apoptosis in mammalian cell 
cultures, our study will focus not only at the apoptotic pathway but will also expand 
to metabolic network to set up a link between cell growth and apoptosis. These 
studies maybe validate our models to further characterize the apoptotic response 
and behavior in mammalian cell culture. These micro scale data can bring us some 
meaningful information to understand the biological phenomena: from inside of cell 
to the outside of medium environment, and in setting up the bridge to the 
relationship between cell proliferation and apoptosis transition. 
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Appendix A. Model Development for Flux 
Analysis 
The metabolic reaction network was constructed as described in section7.2. 
In the case of healthy cells, cell growth reaction was used. However, in the case of 
apoptotic cells, cells don't grow and some of DNA will be damaged during the 
process of apoptosis. Subsequently, apoptotic bodies will be formed. A reaction of 
apoptotic complex was induced. Only one reaction v7a(a) or v7a(b) was used at a 
time. Biomass v7a(a) was used in healthy model and apoptotic complex v7a(b) was 
used in apoptotic model. v79 and intermediate Damaged DNA were used only in 
apoptotic model. In both cases, the degrees of freedom were 27. 
Cytosol Membrane Transport 
1 GLC(ex) ->GLC 
2 ALA(ex)+1/3 ATP+-+ALA 
3 ARG(ex) +1/3 ATP +-+ARG +1/3 ADP 
4 ASN(ex) +1/3 ATP +-+ASN+1/3 ADP 
5 ASP( ex) +ATP +-+ASP+ ADP 
6 CYS(ex) +1/3 ATP +-+CYS+1/3 ADP 
7 GLU(ex)+ATP+-+GLU+ADP 
8 GLY(ex) +-+GLY 
9 HIS( ex) +1/3 ATP +-+HIS+1/3 ADP 
10 ILE(ex) +1/3 ATP +-+ILE+1/3 ADP 
11 LEU( ex) +1/3 ATP +-+LEU+1/3 ADP 
12 LYS(ex) +1/3 ATP <->L YS+1/3 ADP 
13 MET(ex) +1/3ATP +-+MET+1/3ADP 
14 PHE(ex) +1/3 ATP +-+PHE+1/3 ADP 
15 PRO( ex) +1/3 ATP +-+PR0+1/3 ADP 
16 SER(ex) +1/3 ATP +-+SER+1/3 ADP 
17 THR(ex) +1/3 ATP +-+ THR+1/3 ADP 
18 TRP(ex) +1/3 ATP +-+ TRP+1/3 ADP 
19 TYR(ex) +1/3 ATP .... TYR+1/3 ADP 
20 VAL( ex) +1/3 ATP +-+VAL +1/3 ADP 
21 LAC-> LAC( ex) 
22 NH3->NH3(ex) 
23 C02->C02(ex) 
Glycolysis 
20 
21 
24 GLC+ATP--+ADP+GSP 
25 GSP +-+FSP 
26 FSP + ATP +-+ 2GAP+ADP 
27 ADP+GAP+NAD+--+ATP+H20 +NADH+PEP 
28 ADP+PEP--+ATP+PYR 
29 NADH+PYR +-+LAC+NAD 
Pentose Phosphate pathway 
30 GSP + 2NADP+ --+ 2NADPH + C02 + R5P 
31 2R5P--+ GAP+ S7P 
32 GAP + S7P --+ E4P + FSP 
33 X5P + E4P --+ FSP + GAP 
Mitochndrial Transport 
34 PYR +-+PYR(m) 
35 MAL+-+MAL(m) 
36 AKG+-+AKG(m) 
37 MAL +CIT(m) +-+MAL(m)+CIT 
38 ASP(m)+GLU +-+ASP+GLU(m) 
39 GLU(c) --+GLU(m) 
Anaplerotic reactions 
40 PYR(m)+NAD(m) --+AcCoA(m) +C02+NADH(m) 
41 MAL +NADP--+C02+NADPH+PYR 
42 MAL(m)+NADP(m) --+C02+NADPH(m)+PYR(m) 
43 OAA+ATP--+PEP+ADP+C02 
44 PYR(m)+C02+ATP(m)+-+OAA(m)+ADP(m) 
TCAcycle 
45 AcCoA (m)+ OAA(m)--+CIT(m) 
46 CIT(m)+NAD(m) --+AKG(m)+ C02+NADH(m) 
47 AKG(m)+NAD(m) --+SUCCoA(m)+C02+NADH(m) 
48 GDP(m)+SUCCoA(m)+FAD(m)--+FUM(m)+FADH2(m)+GTP(m) 
49 FUM(m)+H20+-+MAL(m) 
50 MAL(m)+NAD(m) --+OAA(m)+NADH(m) 
51 MAL +NAD --+OAA+NADH 
Amino acid metabolism 
52 ARG+AKG+NAD +-+2GLU(c)+NADH(c)+C02+ NH4+ 
53 ASN+-+ASP+NH4+ 
54 ASP+AKG +-+OAA+GLU 
55 ASP(m)+AKG(m) +-+OAA(m)+GLU(m) 
56 CYS+AKG--+PYR+GLU+ NH4+ 
57 GLN+-+GLU+ NH4+ 
58 GLU(m)+NADP+(m) --+AKG(m)+NADPH(m)+ NH4+ 
59 GLU+PYR +-+AKG+ALA 
60 2GLY+NAD+-+SER+NADH+C02+ NH4+ 
61 HIS+NAD+--+GLU+C02+NH4++NADH 
62 ILE+AKG+ATP(m)+NAD+(m)+FAD+(m)--+GLU+AcCoA(m)+NADH(m)+FADH(m)+SUCCoA(m)+ADP(m) 
63 LEU+AKG+ATP(m)+FAD+(c)--+GLU+3AcCoA(m)+FADH2(m)+ADP(m) 
64 LYS+AKGNADPH+2NAD++2NAD+(m)+FAD(m)--+2GLU+2C02+2AcCoA(m)+2NADH(m)+2NADH+FADH2(m)+NADP+(m) 
65 MET+SER+3ATP+ATP(m)+NAD+(m)--+CYS+SUCCoA(m)+C02+NH4++3ADP+ADP(m)+NADH(m) 
66 PHE+NADPH--+ TYR+NADP+ 
67 PR0+2NAD++-+GLU+2NADH 
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68 SER->NH4+ +PYR 
69 THR+NAD(m)+FAD(m)+NAD->PYR(m)+FADH2(m)+NH4++NADH(m)+C02 
70 TRP+2NAD+(m)+FAD+(m)+NADPH->ALA+4C02+2AcCoA(m)+ NH4++2NADH(m)+FADH2(m)+NADP+ 
71 TYR+AKG->MAL +C02+2AcCoA+GLU 
72 VAL+AKG+ 2NAD+(m)+FAD+(m)->SUCCoA(m)+GLU+ 2NADH(m)+FADH2(m) +C02 
Other reactions 
73 CIT +ATP+-+AcCoA+OAA+ADP 
Synthesis of Macromolecules(DNA, RNA, carbohydrates,lipid and Protein) 
74 R5P+1.295ASP + 0.5 GLY+1.41 GLN+4.7 ATP-> 1.41 GLU+ DNA+0.205 FUM(m) + 4.7ADP 
75 R5P+1.24 ASP+0.5 GLY+1.76 GLN+4.67 ATP-> RNA+1.76 GLU + FUM(m)+4.67 ADP 
76 G6P+3.5 ATP-> TC+3.5 ADP 
77 0.75 GAP+ 0.193 SER + 17 ATP + 9 NADH + 17 NADPH + 17.8AcCoA-> lipid+ 17 ADP + 9 NAD + 17 NADP 
0.095 ALA+ 0.063 ARG + 0.039 ASN + 0.048 ASP+ 0.028 CYS + 0.052 GLN + 0.064 GLU + 0.078 GLY + 0.022 HIS+ 0.052 ILE + 0.088 LEU 
+ 0.089 LYS + 0.02 MET+ 0.021 PHE + 0.028 PRO+ 0.057 SER + 0.061 THR + 0.006 TRP + 0.02 TYR + 0.059 VAL+ 4 ATP _.protein+ 4 
ADP 
Synthesis of biomass 
78 0.00844 DNA+ 0.0246 RNA+ 0.8932 protein+ 0.014671ipid + 0.059 TC _.CELL 
Internal balanced metabolites 
No. Internal metabolite No. Internal metabolite No. Internal metabolite 
1 AcCoA 19 GAP 37 PEP 
2 AcCoA(m) 20 GLC 38 PHE 
3 AKG 21 GLN 39 PRO 
4 AKG(m) 22 GLU 40 Protein 
5 ALA 23 GLU(m) 41 PYR 
6 ARG 24 GLY 42 PYR(m) 
7 ASN 25 GLY(m) 43 R5P 
8 ASP 26 HIS 44 RNA 
9 ASP(m) 27 ILE 45 S7P 
10 CIT 28 LEU 46 SER 
11 CIT (m) 29 Lipid 47 SER(m) 
12 C02 30 LYS 48 SucCoA(m) 
13 CYS 31 MAL 49 TC 
14 DNA 32 MAL(m) 50 HHR 
15 E4P 33 MET 51 TRP 
16 F6P 34 NH4 52 TYR 
17 FUM(m) 35 OAA 53 VAL 
------- -------------------------------
18 G6P 36 OAA(m) 54 X5P 
Balance of energetic cofactors 
As is it documented in the literature, energetic cofactors ATP, NAD(P)H and 
FADH2 cannot be regarded as internal balanced metabolites. Assuming that 1 mol 
ofNAD(P)H yields 2.5 mol of ATP, 1 mol ofFADH2 yields 1.5 mol of ATP and 1 mol 
GTP equals 1 mol of ATP, the respiration reactions are considered as: 
Healthy Model 
2.5ADP(m)+NADH(m)-+2.5ATP(m)+NAD(m) 
1.5ADP(m)+FADH2(m)-+ 1.5ATP(m)+FAD(m) 
The metabolism ofCHO cells considered in the healthy condition has 78 
reactions and 54 balanced intermediates. The 20 extracellular metabolites present 
in the medium which are either nutrients or byproducts of excretion were 
measured. However, the system of flux analysis is underdetermined, with commonly 
available measurements in our research. Linear programming was used to reduce 
the range of solution. The objective function is maximization of cell growth rate. 
Apoptotic Model 
In this case, 77 reactions and 54 balanced intermediates were used. In order 
to reduce degrees of freedom and to characterize the feasible set of solutions using 
the extracellular measurements only, some additional constraints and assumptions 
were used. 
1) No catabolism of threonine, that is v69 is 0. Zamorano et 
al[1]applied this assumption to study metabolic flux analysis of an 
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underdetermined network of CHO cells. Since threonin catabolism 
utilizes serine hydroxymethtrasferase (SHMT) to generate Acetyl-CoA 
and glycine. In apoptotic condition, glycine shows negative uptake 
behavior indicating that threonine catabolism is not active and the uptake 
of threonine works for the cellular macromolecule synthesis. 
2) No Phospoenolpyruvate carboxkinase (PEPCK) activity. FBA 
result in healthy cells shows that reaction v 43 is 0. Also as is it reported in 
literature, the short or lack of PEPCK exists in various mammalian cell 
lines, such as CHO, hybridoma, and BHK celllines[2-4]. In apoptotic 
condition, v 43 is imposed as 0. 
3) Zamaraeva et al argued that cell undergoing apoptosis exhibit 
an increase in cytosolic ATP with little increase in total cellular ATP[S]. 
ATP I ADP exchange allows ATP to move out of the mitochondria and ADP 
to move in. Vander et al reported that an early event in apoptosis is a 
defect in mitochondrial ATP 1 ADP exchange and growth factor 
withdrawal leads to a decline in cellular ATP stores and a concomitant 
increase in cytosolic ADP[6]. The mitochondrial ATP I ADP exchange 
reaction: ATP(m)+ADP ~-?ATP+ADP(m) was selected as objection 
function. Minimizing this will reduce the total cellular ATP and increase 
the ratio of cytosolic ATP to cellular ATP, having a good agreement with 
literature mentioned above. Also the minimum of the mitochondrial 
ATP I AD P exchange also describes mitochondrial dysfunction. 
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Abbreviation 
(c) 
(m) 
AcCoA 
ADP 
AKG 
ALA 
AMP 
ARG 
ASN 
ASP 
ATP 
CIT 
Co A 
C02 
CYS 
E4P 
F6P 
F1,6P 
FAD(H2) 
FUM 
G6P 
GLC 
GLN 
GLU 
GLY 
HIS 
LAC 
ILE 
LEU 
LYS 
MAL 
MET 
NAD(H) 
NADP(H) 
NH4+ 
OAA 
PEP 
PHE 
Pi 
PRO 
PYR 
R5P 
RNA 
Description 
Cytosolic 
Mitochondrial 
Acetyl Coenzyme A 
Adenosine diphosphate 
-Ketoglutarate 
Alanine 
Adenosine monophosphate 
Arginine 
Asparagine 
Aspartate 
Adenosine triphosphate 
Citrate 
CoenzyhmeA 
Carbondioxide 
Cysteine 
Erythrose-4-phosphate 
Fructose-6-phosphate 
Fructose-1, 6-biphosphate 
Falvine adenosine dinucleotide (reduced) 
Fumarate 
Glucose 6-phosphate 
Glucose 
Glutamine 
Glutamate 
Glycine 
Histidine 
Lactate 
Isoleucine 
Leucine 
Lysine 
Malate 
Methionine 
Nicotinamide adenine dinucleotide (reduced) 
Nicotinamide adenine dinucleotide phosphate 
(reduced) 
Ammonium 
Oxaloacetate 
Phosphoenolpyruvate 
Phenylalanine 
Orthophosphate 
Proline 
Pyruvate 
Ribose 5-phosphate 
Average RNA bound nucleic acid (mol. wt. 325.39) 
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S?P 
SER 
sue 
SucCoA 
THR 
TRP 
TYR 
VAL 
XSP 
Sedoheptulose-? -phosphate 
Serine 
Succinate 
Succinyhl coenzyme A 
Threonine 
Tryptophan 
Tyrosine 
Valine 
Xylulose 5-phosphate 
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Appendix B Biomass Composition 
The biomass composition of the CHO TF 70R cells was taken from resource of 
[1], and is given as follows. The dry weight of cell was 320!lg/106 cells 
Macromolecules Molar Fraction AverageMW 
Proteins 70.6% 108[1] 
Lipids 7.7% 717[2] 
DNA 1.9% 307.5[3] 
RNA 5.8% 321.6[3] 
carbohydrates 7.0% 162[2] 
The amino acid composition of cellular proteins 
The average molecular weight was calculated to be 108 from the molar 
fraction of amino acids 
Amino Acid Molar Fraction Amino Acid Molar Fraction 
ALA 0.95% LEU 0.88% 
ARG 0.63% LYS 0.89% 
ASP 0.48% MET 0.20% 
ASN 0.39% PHE 0.21% 
CYS 0.28% PRO 0.28% 
GLN 0.52% SER 0.57% 
GLU 0.64% THR 0.61% 
GLY 0.78% TRP 0.06% 
HIS 0.22% TYR 0.20% 
ILE 0.52% VAL 0.59% 
27 
1. Altamirano C, I.A., Casablancas A, Gamez X, Cairo JJ, Godia C., Analysis of CHO 
cells metabolic redistribution in a glutamate-based defined medium in 
continuous culture. Biotechnology Progress, 2001. 17(6): p. 1032-1041. 
2. Deshpande, R.R., Mammalian Cell Culture: High Throughput applications of 
Oxygen Sensor Plates and Cellular Physiological Studies Using 13C-Labeling, in 
Biochemical Engineering Institute. 2007, Saarland University: 
Saarbriicken,Germany. 
3. Lander ES, L.L., Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, 
Doyle M, FitzHugh W, Funke R, GageD, Harris K, Heaford A, Howland J, Kann 
L, Lehoczky J, LeVineR, McEwan P, McKernan K, Meldrim J, Mesirov JP, 
Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, 
Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, 
Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, 
Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, 
Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, 
McMurray A, Matthews L, MercerS, MilneS, Mullikin JC, Mungall A, Plumb R, 
Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, 
McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish 
WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer 
JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, 
BranscombE, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng 
JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, 
Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker 
ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama 
A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, 
Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brattier P, Bruls 
T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield 
M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, 
Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, 
28 
Madan A, Qin S, Davis RW, Federspiel NA, Ahola AP, Proctor MJ, Myers RM, 
Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, 
Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe 
BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de Ia 
Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, 
Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, 
Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy 
SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, 
Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, 
Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, 
Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Panting 
CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-
Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, WolfYI, 
Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, 
Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, 
Shizuya H, Choi S, Chen YJ; International Human Genome Sequencing 
Consortium., Initial sequencing and analysis of the human genome. Nature, 
2001.409: p. 860-921. 
29 
